Closure devices, systems, and methods

Information

  • Patent Grant
  • 9414824
  • Patent Number
    9,414,824
  • Date Filed
    Thursday, July 3, 2014
    10 years ago
  • Date Issued
    Tuesday, August 16, 2016
    8 years ago
Abstract
The present disclosure includes vessel closure devices, systems, and methods. A closure device configured to close an opening in a body lumen may include an elongate member having a distal end and a proximal end. An anchor member may be disposed on the elongate member proximate the distal end of the elongate member. A cap member may also be disposed on the elongate member a distance from the distal end of the elongate member. The anchor member and the cap member cooperate to close the opening in the body lumen.
Description
BACKGROUND

1. Technical Field


The present disclosure relates generally to medical devices, systems, and methods. In particular, the present disclosure relates to vessel closure devices, systems, and methods.


2. Technology


Catheterization and interventional procedures, such as angioplasty or stenting, generally are performed by inserting a hollow needle through a patient's skin and tissue into the patient's vascular system. A guidewire may be advanced through the needle and into the patient's blood vessel accessed by the needle. The needle is then removed, enabling an introducer sheath to be advanced over the guidewire into the vessel, e.g., in conjunction with or subsequent to a dilator.


A catheter or other device may then be advanced through a lumen of the introducer sheath and over the guidewire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate introducing various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss during a procedure.


Upon completing the procedure, the devices and introducer sheath are removed, leaving a puncture site in the vessel wall. Traditionally, external pressure is applied to the puncture site until clotting and wound sealing occur; however, the patient must remain bedridden for a substantial period after clotting to ensure closure of the wound. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a physician's or nurse's time. It is also uncomfortable for the patient and requires that the patient remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.


BRIEF SUMMARY

The present disclosure includes vessel closure devices, systems, and methods. In particular, the devices, systems, and methods of the present disclosure may allow a medical service provider to efficiently and quickly close an opening in a body lumen in a cost effective manner. In addition, the devices, systems, and methods of the present disclosure may allow for the closing of smaller body lumen openings using fewer parts than prior devices and systems.


According to one embodiment of the present disclosure, a closure device configured to close an opening in a body lumen may include an elongate member having a distal end and a proximal end. In addition, an anchor member may be disposed on the elongate member proximate the distal end of the elongate member. A cap member may also be disposed on the elongate member a distance from the distal end of the elongate member.


These and other advantages and features of the present disclosure will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

To further clarify the advantages and features of the present disclosure, a more particular description of the disclosure will be rendered by reference to example embodiments thereof which are illustrated in the appended drawings. It is appreciated that these drawings depict only example embodiments of the disclosure and are therefore not to be considered limiting of its scope. The example embodiments will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates an example closure device for closing an opening in a body lumen or other tissue;



FIG. 2 illustrates an another example closure device for closing an opening in a body lumen or other tissue;



FIG. 3A illustrates an example closure system for closing an opening in a body lumen or other tissue;



FIG. 3B illustrates an additional example closure system;



FIG. 3C illustrates a further example closure system; and



FIGS. 4-11 illustrate an example method of closing a lumen opening.





DETAILED DESCRIPTION

The present disclosure includes devices, systems, and methods for closing an opening in a body lumen or other tissue. In particular, an example closure system may allow for at least one of reduced production costs, ease of use, and more effective hemostasis. In addition, embodiments of the closure system disclosed herein may allow for the closure of smaller openings in body lumens or other tissue.


In one embodiment, the closure system may include a closure device. The closure device may include an elongate member, such as a suture or shaft, an anchor member (or foot), and a cap member. The closure device may be disposed within or deployed by the closure system. The closure system may include an outer member, an inner member, an intermediate member, or combinations thereof configured to deploy a closure device from the closure system.


Reference is now made to FIG. 1, which illustrates an example closure device 100. The closure device 100 may include a plurality of closure members 110 coupled to an elongate member 120. In particular, the plurality of closure members 110 may include an anchor member 110a and/or a cap member 110b. In one embodiment, the anchor member 110a may be disposed near a distal end of the elongate member 120. In a further embodiment, the cap member 110b may be proximate the anchor member 110a and/or spaced a distance away from the distal end of the elongate member 120.


The anchor member 110a may be configured to be deployed through an opening in a body lumen in order to secure the closure device 100 from a point distal to the lumen opening. For example, the anchor member 110a may be configured to move from a compressed, folded, or compacted first position having a dimension smaller than a lumen opening to a deployed, unfolded, or expanded second position having a dimension larger than the lumen opening. As a result, the anchor member 110a may pass through the lumen opening while in the first position and thereafter may move to the second position and provide an anchor against the distal side of the lumen wall proximate the lumen opening.


The elongate member 120 may extend proximally from the deployed anchor member 110a and/or may be tensioned to secure the anchor member 110a proximate the lumen opening and/or against a distal surface of a lumen wall once deployed. In a further embodiment, the elongate member 120 may pass through the cap member 110b, which may be deployed at a position proximal of the lumen wall. Once deployed, the cap member 110b may be moved in a distal direction and/or may engage the proximal surface of the lumen wall. As a result, the anchor member 110a and/or cap member 110b may at least partially close the lumen opening.


The closure device 100 including, but not limited to, the anchor member 110a and/or cap member 110b, may include one or more biocompatible, bioabsorbable, bioresorbable, other materials, or combinations thereof. Examples of such materials may include a suitable hydrogel, hydrophilic polymer, biodegradable polymers, bioabsorbable polymers and bioneutral polymers. Examples of such polymers may include poly(alpha-hydroxy esters), polylactic acids, polylactides, poly-L-lactide, poly-DL-lactide, poly-L-lactide-co-DL-lactide, polyglycolic acids, polyglycolide, polylactic-co-glycolic acids, polyglycolide-co-lactide, polyglycolide-co-DL-lactide, polyglycolide-co-L-lactide, polyanhydrides, polyanhydride-co-imides, polyesters, polyorthoesters, polycaprolactones, polyesters, polyanydrides, polyphosphazenes, polyester amides, polyester urethanes, polycarbonates, polytrimethylene carbonates, polyglycolide-co-trimethylene carbonates, poly(PBA-carbonates), polyfumarates, polypropylene fumarate, poly(p-dioxanone), polyhydroxyalkanoates, polyamino acids, poly-L-tyrosines, poly(beta-hydroxybutyrate), polyhydroxybutyrate-hydroxyvaleric acids, combinations thereof, and/or the like.


In one embodiment, the closure device 100, including, but not limited to, the anchor member 110a and/or cap member 110b, may be coated with an active pharmaceutical ingredient with or without a polymeric carrier. The active pharmaceutical ingredient can be any drug. In one embodiment, the pharmaceutical ingredient may increase tissue growth.


The polymeric coating and drug may be configured to cooperate so as to form a diffusion pathway (e.g., lipophilic, hydrophilic, and/or amphipathic) with tissue when at least a portion of the closure device 100 engages tissue. This may facilitate diffusion into the tissue instead of into a body fluid passing over the closure device 100.


The closure device 100 or any portion thereof may be loaded with and deliver beneficial agents or drugs, such as therapeutic agents, pharmaceuticals and radiation therapies. Accordingly, the closure device 100 and/or coating material may contain a drug or beneficial agent to improve the use of the closure device 100. Such drugs or beneficial agents may include antithrombotics, anticoagulants, antiplatelet agents, thrombolytics, antiproliferatives, anti-inflammatories, hemostatic agents, agents that inhibit hyperplasia, inhibitors of smooth muscle proliferation, antibiotics, growth factor inhibitors, or cell adhesion inhibitors, as well as antineoplastics, antimitotics, antifibrins, antioxidants, agents that promote endothelial cell recovery, antiallergic substances, radiopaque agents, viral vectors having beneficial genes, genes, siRNA, antisense compounds, oligionucleotides, cell permeation enhancers, and combinations thereof. Another example of a suitable beneficial agent is described in U.S. Pat. Nos. 6,015,815 and 6,329,386 entitled “Tetrazole-containing rapamycin analogs with shortened half-lives”, the entireties of which are herein incorporated by reference.


The anchor member 110a and/or cap member 110b may include any shape configured to facilitate obstruction of a lumen opening. In one embodiment, the anchor member 110a and/or cap member 110b may have a disc-like shape. For example, the anchor member 110a and/or cap member 110b may include a generally flat piece of material that may be circular or oval in shape. The anchor member 110a and/or cap member 110b may incorporate other shapes and/or configurations. For example, the anchor member 110a and/or cap member 110b may have an elliptical and/or polygonal shape. In a further embodiment, the closure members 110 may be rectangular in shape along the length thereof with rounded and/or triangular ends or corners.


In one implementation, the thickness of the anchor member 110a and/or cap member 110b may be continuous throughout the anchor member 110a and/or cap member 110b. In further implementations, however, the thickness of the anchor member 110a and/or cap member 110b may vary as desired for a particular application. For example, the thickness of the anchor member 110a and/or cap member 110b may be greater near the center than along the outer edge of the anchor member 110a and/or cap member 110b. In a yet further example, the thickness of the anchor member 110a and/or cap member 110b may be greater along a first axis extending through the center of the anchor member 110a and/or cap member 110b and progressively thinner extending away from the first axis. As a result, the anchor member 110a and/or cap member 110b may allow bending about the first axis but may resist bending about an axis perpendicular to or different from the first axis. In yet further implementations, the thickness of the anchor member 110a and/or cap member 110b may vary as desired to achieve a particular strength, rigidity, flexibility, and/or other mechanical property.


In one implementation, the anchor member 110a and cap member 110b may have the same shape, size, coating, and/or other characteristics, and/or combinations thereof. In a further embodiment, the shape, size, coating, and/or other characteristics of the anchor member 110a may be different than those of the cap member 110b.


As mentioned, the closure device 100 may include an elongate member 120. In one embodiment, the anchor member 110a may be coupled to a distal end of the elongate member 120 and/or the cap member 110b may be disposed on the elongate member 120 at a position along the length of the elongate member 120. The elongate member 120 may include one or more bioabsorbable materials and/or beneficial agents, such as any bioabsorbable material and/or beneficial agents disclosed herein. In a further embodiment, the elongate member 120 may include a bioabsorbable metal, alloy, polymer, plastic, composite, other materials, or combinations thereof. The elongate member 120 may include a single limb, such as disclosed in FIG. 1, or may include a plurality of limbs, such as disclosed in FIG. 2. In one example embodiment, the elongate member 120 may include a suture or a plurality of sutures. In a further embodiment, the elongate member 120 may include an elongate shaft or a plurality of elongate shafts. In a yet further embodiment, at least a portion of the elongate member 120 may be generally tubular or hollow.


The closure device 100 may be configured to resist proximal movement of the cap member 110b and/or distal movement of the anchor member 110a after deployment. For example, in one embodiment, a knot may be disposed on the elongate member 120 proximal of the cap member 110b to secure the cap member 110b and/or anchor member 110a in place. In a further embodiment, a cleat, such as a bioabsorbable plastic cleat, may be positioned to secure the cap member 110b and/or anchor member 110a in place. For example, the cleat may be positioned along the elongate member 120 proximal of and/or abutting the cap member 110b. The cleat may maintain sufficient tension in the elongate member 120 to maintain the cap member 110b and anchor member 110a securely in a deployed position, such as in apposition with the lumen wall and/or lumen opening therebetween. In particular, the anchor member 110a and cap member 110b may sandwich the lumen wall surrounding a lumen opening to achieve closure of the lumen opening.


In a further embodiment, the closure device 100 may include a mechanism to lock and/or secure the anchor member 110a and cap member 110b in place. In one example embodiment, the elongate member 120 may have a uniform thickness along its length and/or pass through an aperture in the cap member 110b configured to produce sufficient frictional force between the cap member 110b and elongate member 120 to resist relative movement between the elongate member 120 and cap member 110b. In particular, this configuration may allow the cap member 110b to be deployed by sliding the cap member 110b in a distal direction along the elongate member 120 to secure the cap member 110b and anchor member 110a in place. Once deployed, the frictional force between the elongate member 120 and the cap member 110b may prevent and/or resist further movement by the cap member 110b and/or anchor member 110a.


In a further embodiment, the closure device 100 may include a barbed and/or ratchet design to secure the cap member 110b and anchor member 110a in the deployed configuration. For example, the elongate member 120 may include a plurality of projections 125 disposed along the length thereof. The projections 125 may include barbs, teeth, ridges, and/or other similar projections. The projections 125 may be configured to allow the cap member 110b to move in a distal direction but may resist/prevent movement by the cap member 110b in a proximal direction. For example, the projections 125 may be angled and/or extend in a distal direction to allow the cap member 110b to pass over the projections 125 in a distal direction but to prevent the cap member 110b from then passing back over the projections 125 in a proximal direction. Accordingly, once the anchor member 110a is deployed and/or secured against the distal surface of the lumen wall, the cap member 110b may be advanced along the elongate member 120 over the projections 125. The cap member 110b may be secured against the proximal surface of the lumen wall and/or held in place by one or more of the projections 125 of the elongate member 120.


In yet a further embodiment, the locking mechanism (i.e., knot, cleat, projections, etc.) may be independent of the cap member 110b. In particular, decoupling the locking mechanism from the cap member 110b may allow for the independent optimization of the locking mechanism and/or the cap member 110b. For example, the closure device 100 may further include a sliding collet that may be advanced along the elongate member 120 and/or lock the cap member 110b in place once deployed. The collet may incorporate one or more locking features that may be otherwise incorporated in the cap member 110b as explained in more detail herein.


In a further embodiment, the cap member 110b may be secured in place using a hollow elongate member 120 and a plug configured to be inserted into the elongate member 120. Once the anchor is deployed, the cap member 110b may be moved along the hollow elongate member 120 into apposition with the anchor member 110a, thereby applying pressure to opposite sides of the lumen wall near the lumen opening. A plug may be driven into the hollow elongate member 120 to expand the elongate member 120 proximal of the cap member 110b. As a result, the expanded portion of the hollow elongate member 120 may secure the cap member 110b in place by limiting movement by the cap member 110b in a proximal direction.


Reference is now made to FIG. 2 which illustrates another example closure device. The example closure device 200 of this configuration may be functionally similar to the example closure device 100 previously described above and shown in FIG. 1 in most respects. Certain features will not be described in relation to this configuration where those components may function in the manner as described above and are hereby incorporated into this additional configuration described below. Like structures and/or components may be given like reference numerals.


In one embodiment, the closure device 200 may include a plurality of closure members 210 coupled to a plurality of elongate members 220a, 220b. The plurality of closure members 210 may include an anchor member 210a and/or a cap member 210b. In particular, the anchor member 210a may be coupled to the distal ends of the elongate members 220a, 220b and/or the cap member 210b may be disposed on the elongate members 220a, 220b proximal of the anchor member 210a.


In one embodiment, the elongate members 220a, 220b may include plurality of sutures extending together along at least a portion of the length of the closure device 300. In a further example, the elongate members 220a, 220b may include shafts and/or sutures. The elongate members 220a, 220b may be coupled together and/or to the anchor member 210a at their distal ends. For example, the elongate members 220a, 220b may be coupled together and/or coupled to the anchor member 210a using a distal knot 230a. In particular, the distal knot 230a may be a heat formed knot. In a yet further embodiment, the elongate members 220a, 220b may form a proximal knot 230b at a position proximal of the cap member 210b. The proximal knot 230b may be configured to be advanced in a distal direction and/or secure the cap member 210b in apposition to the anchor member 210a on opposite sides of a lumen wall. The elongate members 220a, 220b may be flexible and include surgical silk or thread, which may be bioabsorbable. Alternatively, the elongate member 120 (in FIG. 1) may be relatively stiff.


Reference is now made to FIG. 3A, which illustrates an example closure system 1000 for closing an opening in a body lumen or other tissue. In one embodiment, the closure system 1000 may include a closure device 300, a generally tubular outer member 1010, a generally tubular inner member 1030, and a generally tubular intermediate member 1020. The example closure device 300 included in the closure system 1000 of this configuration may be functionally similar to the example closure devices 100, 200 previously described above and shown in FIGS. 1-2 in most respects, where certain features will not be described in relation to this configuration wherein those components may function in the manner as described above and are hereby incorporated into this additional configuration described below. Like structures and/or components may be given like reference numerals.


In one embodiment, the closure device 300 may include an anchor member 310a, a cap member 310b, and an elongate member 320. The closure device 300 may be disposed at least partially within the outer member 1010 proximate a distal opening 1015 of the outer member 1010. The intermediate member 1020 may be disposed at least partially within the outer member 1010 proximal of the closure device 300. In particular, the distal end of the intermediate member 1020 may be disposed within the proximal end of the outer member 1010. The proximal end of the intermediate member 1020 may also extend out of the proximal end of the outer member 1010 for operation by a medical practitioner. The inner member 1030 may be disposed at least partially within the outer member 1010 and/or the intermediate member 1020. In a further embodiment, the closure device 300 may be disposed on or along side the inner member 1030. In particular, the anchor member 310a and/or cap member 310b may fold or wrap at least partially around the inner member 1030. The elongate member 320 of the closure device 300 may extend through a distal opening in the inner member 1030 and out a proximal opening in the inner member 1030 for operation by a medical practitioner.


The outer member 1010 may be configured to advance to a lumen opening while carrying the other components of the closure system 1000. In one embodiment, the outer member 1010 may have a generally tapered distal end to facilitate entry into a body lumen through a lumen opening. The outer member 1010 may have a distal opening 1015 through which the inner member 1030 may pass and through which the closure device 300 may be deployed. In one example embodiment, the outer member 1010 may include a non-rigid catheter.


In further implementations, the outer member 1010 may have any dimensions desired. For example, as shown in FIG. 3A, the outer member may have a substantially constant diameter along a majority of its length. However, in further implementations, the outer member 1010 may have a varying diameter. In a yet further implementation, the thickness of the outer member 1010 may vary along its length. For example, the thickness of the outer member may increase near the distal end. As a result, the inner diameter of the outer member may decrease near the distal end, creating a conical or funnel-like interior surface of the outer member 1010. The reduced inner diameter of the outer member 1010 may allow for a reduction of setting of the anchor member 310a and/or cap member 310b from age and/or sterilization. In a yet further implementation, the anchor member 310a and/or cap member 310b may be disposed with the outer member proximate its proximal end or within a handle portion of the closure system 1000 prior to deployment through the distal opening 1015 of the outer member 1010.


The intermediate member 1020 may be configured to deploy the anchor member 310a and/or cap member 310b of the closure device 300 through the distal opening 1015 in the outer member 1010. For example, the intermediate member 1020 may be disposed within the outer member 1010 and positioned proximal of and/or abutting the closure device 300. The intermediate member 1020 may be configured to translate in a distal direction relative to the outer member 1010 in order to push at least a portion of the closure device 300 through the distal opening 1015 of the outer member 1010 and/or to deploy the anchor member 310a and/or cap member 310b. For example, once a distal end of the outer member 1010 has advanced through a lumen opening into a lumen, the intermediate member 1020 may be advanced in a distal direction relative to the outer member 1010 to deploy the anchor member 310a from the distal end of the outer member 1010 and/or into the lumen.


In one embodiment, the intermediate member 1020 may be configured to limit its range of movement in order to reduce instances of inadvertent deployment of the cap member 310b within the lumen. For example, the distance that the proximal end of the intermediate member 1020 extends beyond the proximal end of the outer member 1010 may be equal to the distance necessary to deploy the anchor member 310a. In a further embodiment, the intermediate member 1020 may be configured to limit further distal movement of the intermediate member 1020 relative to the outer member 1010 once the relative movement necessary to deploy only the anchor member 310a has been achieved. For example, the proximal end of the intermediate member 1020 may include one or more flanges at its proximal end configured to abut the proximal end of the outer member once the relative movement necessary to deploy only the anchor member 310a has been achieved.


The inner member 1030 may pass through the intermediate member 1020 and/or outer member 1010 and extend out the distal and/or proximal ends of the outer member 1010 and/or intermediate member 1020, respectively. In one embodiment, the distal end of the inner member 1030 may be configured to at least partially close the distal opening 1015 in the outer member 1010 in order to reduce instances of premature and/or inadvertent deployment of the closure device 300. In a further embodiment, the inner member 1030 may include an inner lumen. For example, the inner lumen of the inner member 1030 may operate as a guidewire lumen, such that the closure system 1000 may advance over a guidewire into a body lumen through an opening in the body lumen wall. As explained above, the elongate member 320 of the closure device 300 may also be at least partially disposed through the inner member 1030. In addition, the inner member 1030 may be configured to operate as and/or include a marker port and/or a flow back lumen, such as blood mark race and/or bleed back lumen, to indicate when the distal end of the closure system 1000 has entered the body lumen.


Reference is now made to FIG. 3B, which illustrates an additional example closure system 1000′ in accordance with an implementation of the present invention. The closure system 1000′ of this configuration may be functionally similar to the example closure system 1000 previously described above and shown in FIG. 3A in most respects, wherein certain features will not be described in relation to this configuration where those components may function in the manner as described above and are hereby incorporated into this additional configuration described below. Like structures and/or components may be given like reference numerals.


In particular, the closure system 1000′ may differ from the closure system 1000 of FIG. 3A by integrating the intermediate member 1020 and inner member 1030 into a single component, namely intermediate member 1020′. For example, the intermediate member 1020′ may include a proximal portion 1020a′ and a distal portion 1020b′. In one implementation, the proximal portion 1020a′ may have a larger diameter than the distal portion 1020b′. The anchor member 310a′ and/or cap member 310b′ of the closure device may be disposed on or proximate to the distal portion 1020b′ of the intermediate member 1020′ within the outer member 1010′ and distal of the proximal portion 1020a′ of the intermediate member 1020′. When the intermediate member 1020′ is advanced in a distal direction, the proximal portion 1020a′ may assist in pushing or deploying the anchor member 310a′ and/or cap member 310b′ through a distal opening 1015′ in the outer member 1010′. The intermediate member 1020′ may also define a lumen through which the elongate member 320′, a guidewire, or body fluid may pass. As a result, the closure system 1000′ may have less moving parts than the closure system 1000 of FIG. 3A but may, nonetheless, operate similarly to deploy the closure device 300′ to close a body lumen opening.


Reference is now made to FIG. 3C, which illustrates an additional example closure system 1000″ in accordance with an implementation of the present invention. The closure system 1000″ of this configuration may be functionally similar to the example closure systems 1000, 1000′ previously described above and shown in FIGS. 3A-3B in most respects, wherein certain features will not be described in relation to this configuration where those components may function in the manner as described above and are hereby incorporated into this additional configuration described below Like structures and/or components may be given like reference numerals.


As shown in FIG. 3C, in addition to or in conjunction with the closure device 300″, the closure system 1000″ may include a plug 400. The plug 400 may be configured to close an opening in a body lumen or a corresponding tissue tract. The plug 400 may be disposed within the closure system 1000″ and configured for deployment proximate the body lumen opening. In particular, the plug 400 may be disposed within the closure system 1000″ on the inner member 1030″ and distal of the intermediate member 1020″. In a further implementation, the plug 400 may be disposed on the elongate member 320″ of the closure device 300″ proximal of the anchor member 310a″ and/or cap member 310b″. The plug 400 may comprise any material known or used for closing a body lumen opening or tissue tract, including biodegradable materials, bioerodible materials, bioabsorbable materials, bioresorbable materials, other materials, or combinations thereof. In one implementation, the plug 400 may comprise collagen and/or polyethylene glycol.


Reference is now made to FIGS. 4-11 which illustrate an example method of deploying the closure device 300 using the closure system 1000 of FIG. 3. For example, FIG. 4 illustrates that the closure system 1000 may be advanced through a tissue tract and at least partially into a body lumen through a lumen opening to be obstructed or closed. As shown, the closure system 1000 may be advanced into the lumen over a guidewire 1040. In particular, the guidewire may pass through the inner member 1030 of the closure system 1000. The inner member 1030 may include and/or operate as a fluid mark race and/or flow back lumen in order to indicate to a user that the distal end of the closure system 1000 has entered the body lumen. For example, the closure system 1000 may be advanced in an artery, until a pulsatile blood mark is indicated at the proximal end of the inner member 1030.


Once the closure system 1000 is in position with the distal end thereof disposed within the lumen, the inner member 1030 and/or guidewire 1040 may be retracted as illustrated in FIG. 5. In particular, the inner member 1030 may be removed by pulling on the inner member 1030 while stabilizing the remaining components of the closure system 1000. In one embodiment, removing the inner member 1030 from the closure system 1000 may facilitate deployment of the closure device 300 through the distal opening 1015 of the outer member 1010.


Once the inner member 1030 has been removed, the intermediate member 1020 may be advanced in a distal direction to deploy the anchor member 310a of the closure device 300 into the lumen as illustrated in FIG. 6. In one embodiment, the anchor member 310a, which may have been folded and/or otherwise compacted while disposed within the outer member 1010, may expand into a deployed state.


After the anchor member 310a is deployed, the outer member 1010 may be retracted and/or the elongate member 320 of the closure device 300 may be tensioned for the anchor member 310a to engage the distal surface of the lumen wall proximate the lumen opening as illustrated in FIG. 7. The outer member 1010 may continue to retract, and the resulting tension in the elongate member 320 caused by the secured anchor member 310a may deploy the cap member 310b from the distal opening 1015 of the outer member 1010 as illustrated in FIGS. 8-9. In a further embodiment, the intermediate member 1020 may be used to deploy the cap member 310b.


Once the cap member 310b is deployed within the tissue tract proximal of the lumen wall, it may then be advanced into apposition with the anchor member 310a, as illustrated in FIG. 10, in order to engage the anchor member 310a and/or cap member 310b with opposing surfaces of the lumen wall. During this process, the position of the anchor member 310a may be retained by maintaining tension in the elongate member 320 as the outer member 1010 is withdrawn and/or as the cap member 310b is advanced. In a further embodiment, a knot and/or cleat 330 may be advanced along the elongate member 320 of the closure device 300 and/or secure the cap member 310b against the anchor member 310a with the lumen wall sandwiched at least partially therebetween, thereby further securing the closure members in place. In a further embodiment, the elongate member 320 may include a plurality of projections (i.e., 125, FIG. 1) extending from a surface thereof and configured to secure the cap member 310b in place and prevent proximal movement of the cap member 310b relative to the elongate member 320. Once the cap member 310b and anchor member 310a are secured, the elongate member 320 may be trimmed proximal of the cap member 310b, such as by using a suture trimmer 340, and then retracted, as shown in FIG. 11. In a further embodiment, one or more additional locking mechanisms as disclosed in more detail herein may be used to secure the cap member 310b and/or anchor member 310a in place.


Once deployed, the cap member 310b and the anchor member 310a can close or substantially close an opening in a body lumen. The vessel or tissue adjacent the opening can be disposed at least partially between the cap member 310b and the anchor member 310a. As the cap member 310b is advanced, the cap member 310b and the anchor member 310a can apply pressure to the tissue or vessel to hold the tissue in place and close the opening. Further, the cap member 310b and the anchor member 310a may be configured to also bond or become connected to the tissue to further close the opening. Also, the cap member 310b and the anchor member 310a may slightly deform as tension is applied to accommodate the tissue that is between the cap member 310b and the anchor member 310a.


The embodiments of the present disclosure may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the disclosure is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A closure system configured to close an opening in a body lumen, the closure system comprising: a generally tubular outer member having a distal opening and a proximal opening;a generally tubular intermediate member disposed at least partially within the outer member;a generally tubular inner member disposed at least partially within the generally tubular intermediate member, the generally tubular inner member including a lumen; anda closure device disposed at least partially within the outer member and around at least a portion of an outer surface of the generally tubular inner member extending from a distal end towards a proximal end of the generally tubular inner member, the closure device comprising: a suture having a distal end and a proximal end;a monolithic anchor member connected to the suture proximate the distal end of the suture and at least partially wrapped around to at least partially encircle a portion of the generally tubular inner member, the anchor member being elastic such that the anchor member conforms to an inner surface of the body lumen, a knot affixed to a proximal face of the monolithic anchor member; anda cap member connected to the suture a distance from the distal end of the suture, the cap member being configured to conform to an outer surface of the body lumen, wherein the anchor member and the cap member being deformed to close the opening in the body lumen with a convex-like surface of the cap member being disposed toward the monolithic anchor member,wherein the suture extends distally from the distal end of the generally tubular inner member and distal the monolithic anchor in a pre-deployed, delivery configuration.
  • 2. The closure system of claim 1, further comprising a second suture disposed substantially in parallel with the suture.
  • 3. The closure system of claim 1, wherein the suture comprises one or more projections disposed along the length thereof.
  • 4. The closure system of claim 3, wherein the one or more projections are chosen from a group comprising teeth, barbs, and ridges.
  • 5. The closure system of claim 3, wherein the one or more projections are configured to permit movement by the cap member in a distal direction and resist movement by the cap member in a proximal direction.
  • 6. The closure system of claim 1, wherein the cap member is slidably disposed on the elongate member.
  • 7. The closure system of claim 1, wherein the anchor member or cap member comprises a biodegradable material.
  • 8. The closure system of claim 1, wherein the anchor member or cap member is disc shaped.
  • 9. The closure system of claim 1, wherein the anchor member or cap member has a varying thickness.
  • 10. The closure system of claim 1, wherein the suture comprises a bioabsorbable monofilament.
  • 11. The closure system of claim 1, wherein the cap member is coupled to the suture proximate a knot.
  • 12. A closure system comprising: a generally tubular outer member having a distal opening and a proximal opening;a generally tubular intermediate member disposed at least partially within the outer member;a generally tubular inner member disposed at least partially within the generally tubular intermediate member, the generally tubular inner member including a lumen; anda closure device disposed at least partially within the outer member and around at least a portion of an outer surface of the generally tubular inner member extending from a distal end towards a proximal end of the generally tubular inner member, the closure device comprising: a suture having a distal end and a proximal end, the suture being disposed at least partially through the intermediate member;a monolithic anchor member connected to the suture proximate the distal end of the suture, the anchor member being further disposed within the outer member distal of the intermediate member and at least partially wrapped around to at least partially encircle a portion of the generally tubular inner member, the anchor member being elastic such that the anchor member conforms to an inner surface of the body lumen, a knot affixed to a proximal face of the monolithic anchor member; anda cap member connected to the suture a distance from the distal end of the suture and at least partially wrapped around to at least partially encircle another portion of the generally tubular inner member, the cap member being configured to conform to an outer surface of the body lumen, the cap member being further disposed within the outer member proximal of the anchor member and being deformed to close the opening in the body lumen with a convex-like surface of the cap member being disposed toward the monolithic anchor member,wherein the suture extends distally from the distal end of the generally tubular inner member and distal the monolithic anchor in a pre-deployed, delivery configuration.
  • 13. The closure system of claim 12, wherein the outer member comprises a non-rigid catheter.
  • 14. The closure system of claim 12, wherein the inner member comprises a guidewire lumen, fluid marker port, or flow back lumen.
  • 15. The closure system of claim 12, wherein the inner member and the intermediate member are integrated together into a single component.
  • 16. The closure system of claim 12, wherein the intermediate member comprises a pusher tube.
  • 17. The closure system of claim 12, wherein the intermediate member is movable relative to the outer member.
  • 18. The closure system of claim 12, wherein the distal movement of the intermediate member relative to the outer member is limited to the movement necessary deploy the anchor member from the distal opening of the outer member.
  • 19. The closure system of claim 12, further comprising a collagen or polyethylene glycol plug configured to at least partially obstruct a tissue tract proximate a body lumen opening.
  • 20. A method of closing an opening in a lumen wall, the method comprising: advancing the distal end of a closure system over a guidewire into a body lumen, the closure system comprising: a generally tubular outer member having a distal opening and a proximal opening;a generally tubular intermediate member disposed at least partially within the outer member;a generally tubular inner member disposed at least partially within the generally tubular intermediate member, the generally tubular inner member including a lumen; anda closure device disposed at least partially within the outer member and around at least a portion of an outer surface of the generally tubular inner member extending from a distal end towards a proximal end of the generally tubular inner member, the closure device comprising: a suture having a distal end and a proximal end, the suture being disposed at least partially through the intermediate member;a monolithic anchor member connected to the suture proximate the distal end of the suture and at least partially wrapped around to at least partially encircle a portion of the generally tubular inner member, the anchor member being further disposed within the outer member distal of the intermediate member, the anchor member being elastic such that the anchor member conforms to an inner surface of the body lumen; anda cap member disposed on the elongate member a distance from the distal end of the elongate member, the cap member being further disposed within the outer member proximal of the anchor member, the cap member being configured to conform to an outer surface of the body lumen, the cap member being further disposed within the outer member proximal of the anchor member and being deformed to close the opening in the body lumen with a convex-like surface of the cap member being disposed toward the monolithic anchor member, wherein the suture extends distally from the distal end of the generally tubular inner member and distal the monolithic anchor in a pre-deployed, delivery configuration;deploying the anchor member into the lumen;tensioning the suture to engage the anchor member with a distal surface of the lumen wall; anddeploying the cap member and advancing the cap member in a distal direction along the suture to engage a proximal surface of the lumen wall.
CROSS-REFERENCE TO RELATED APPLICATIONS

This U.S. Patent Application is a divisional of U.S. patent application Ser. No. 12/688,065, filed Jan. 15, 2010, which claims the benefit of and priority to U.S. Provisional Patent Application having Ser. No. 61/145,468, filed on Jan. 16, 2009, the disclosures of which are incorporated herein by reference in their entireties.

US Referenced Citations (1040)
Number Name Date Kind
287046 Norton Oct 1883 A
438400 Brenne Oct 1890 A
556082 Boeddinghaus Mar 1896 A
1088393 Backus Feb 1914 A
1123290 Von Herff Jan 1915 A
1331401 Summers Feb 1920 A
1596004 De Bengoa Aug 1926 A
1647958 Ciarlante Nov 1927 A
1880569 Weis Oct 1932 A
2087074 Tucker Jul 1937 A
2210061 Caminez Aug 1940 A
2254620 Miller Sep 1941 A
2316297 Southerland et al. Apr 1943 A
2371978 Perham Mar 1945 A
2453227 James Nov 1948 A
2583625 Bergan Jan 1952 A
2684070 Kelsey Jul 1954 A
2755699 Forster Jul 1956 A
2910067 White Oct 1959 A
2944311 Schneckenberger Jul 1960 A
2951482 Sullivan Sep 1960 A
2969887 Darmstadt et al. Jan 1961 A
3015403 Fuller Jan 1962 A
3113379 Frank Dec 1963 A
3120230 Skold Feb 1964 A
3142878 Santora Aug 1964 A
3209754 Brown Oct 1965 A
3482428 Kapitanov et al. Dec 1969 A
3494533 Green et al. Feb 1970 A
3510923 Blake May 1970 A
3523351 Filia Aug 1970 A
3586002 Wood et al. Jun 1971 A
3604425 Le Roy Sep 1971 A
3618447 Goins Nov 1971 A
3677243 Nerz Jul 1972 A
3757629 Schneider Sep 1973 A
3805337 Branstetter Apr 1974 A
3823719 Cummings Jul 1974 A
3828791 Santos Aug 1974 A
3856016 Davis Dec 1974 A
3874388 King et al. Apr 1975 A
3908662 Razgulov et al. Sep 1975 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
3944114 Coppens Mar 1976 A
3960147 Murray Jun 1976 A
3985138 Jarvik Oct 1976 A
4007743 Blake Feb 1977 A
4014492 Rothfuss Mar 1977 A
4018228 Goosen Apr 1977 A
4047533 Perciaccante et al. Sep 1977 A
4064881 Meredith Dec 1977 A
4112944 Williams Sep 1978 A
4153321 Pombrol May 1979 A
4162673 Patel Jul 1979 A
4169476 Hiltebrandt Oct 1979 A
4192315 Hilzinger et al. Mar 1980 A
4201215 Crossett et al. May 1980 A
4204541 Kapitanov May 1980 A
4207870 Eldridge Jun 1980 A
4214587 Sakura, Jr. Jul 1980 A
4215699 Patel Aug 1980 A
4217902 March Aug 1980 A
4273129 Boebel Jun 1981 A
4274415 Kanamoto et al. Jun 1981 A
4278091 Borzone Jul 1981 A
4317445 Robinson Mar 1982 A
4317451 Cerwin et al. Mar 1982 A
4318401 Zimmerman Mar 1982 A
4327485 Rix May 1982 A
4345606 Littleford Aug 1982 A
4359052 Staub Nov 1982 A
4368736 Kaster Jan 1983 A
4396139 Hall et al. Aug 1983 A
4407286 Noiles et al. Oct 1983 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4428376 Mericle Jan 1984 A
4440170 Golden et al. Apr 1984 A
4449531 Cerwin et al. May 1984 A
4475544 Reis Oct 1984 A
4480356 Martin Nov 1984 A
4485816 Krumme Dec 1984 A
RE31855 Osborne Mar 1985 E
4505273 Braun et al. Mar 1985 A
4505274 Speelman Mar 1985 A
4523591 Kaplan et al. Jun 1985 A
4523695 Braun et al. Jun 1985 A
4525157 Vaillancourt Jun 1985 A
4526174 Froehlich Jul 1985 A
4570633 Golden Feb 1986 A
4586503 Kirsch et al. May 1986 A
4592498 Braun et al. Jun 1986 A
4596559 Fleischhacker Jun 1986 A
4607638 Crainich Aug 1986 A
4610251 Kumar Sep 1986 A
4610252 Catalano Sep 1986 A
4635634 Santos Jan 1987 A
4644956 Morgenstern Feb 1987 A
4651737 Deniega Mar 1987 A
4664305 Blake, III et al. May 1987 A
4665906 Jervis May 1987 A
4687469 Osypka Aug 1987 A
4693249 Schenck et al. Sep 1987 A
4719917 Barrows et al. Jan 1988 A
4724840 McVay et al. Feb 1988 A
4738658 Magro et al. Apr 1988 A
4744364 Kensey May 1988 A
4747407 Liu et al. May 1988 A
4759364 Boebel Jul 1988 A
4771782 Millar Sep 1988 A
4772266 Groshong Sep 1988 A
4777950 Kees, Jr. Oct 1988 A
4789090 Blake, III Dec 1988 A
4832688 Sagae et al. May 1989 A
4836204 Landymore et al. Jun 1989 A
4852568 Kensey Aug 1989 A
4860746 Yoon Aug 1989 A
4865026 Barrett Sep 1989 A
4874122 Froelich et al. Oct 1989 A
4878915 Brantigan Nov 1989 A
4885003 Hillstead Dec 1989 A
4886067 Palermo Dec 1989 A
4887601 Richards Dec 1989 A
4890612 Kensey Jan 1990 A
4900303 Lemelson Feb 1990 A
4902508 Badylak et al. Feb 1990 A
4917087 Walsh et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4929240 Kirsch et al. May 1990 A
4934364 Green Jun 1990 A
4950258 Kawai et al. Aug 1990 A
4957499 Lipatov et al. Sep 1990 A
4961729 Vaillancourt Oct 1990 A
4967949 Sandhaus Nov 1990 A
4976721 Blasnik et al. Dec 1990 A
4983176 Cushman et al. Jan 1991 A
4997436 Oberlander Mar 1991 A
4997439 Chen Mar 1991 A
5002562 Oberlander Mar 1991 A
5007921 Brown Apr 1991 A
5011487 Shichman Apr 1991 A
5015247 Michelson May 1991 A
5021059 Kensey et al. Jun 1991 A
5026390 Brown Jun 1991 A
5030226 Green et al. Jul 1991 A
5032127 Frazee et al. Jul 1991 A
5035692 Lyon et al. Jul 1991 A
5041129 Hayhurst et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5047047 Yoon Sep 1991 A
5053008 Bajaj Oct 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5061283 Silvestrini Oct 1991 A
5078731 Hayhurst Jan 1992 A
5092941 Miura Mar 1992 A
5100418 Yoon et al. Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5108420 Marks Apr 1992 A
5108421 Fowler Apr 1992 A
5114032 Laidlaw May 1992 A
5114065 Storace May 1992 A
5116349 Aranyi May 1992 A
5122122 Allgood Jun 1992 A
5122156 Granger et al. Jun 1992 A
5131379 Sewell, Jr. Jul 1992 A
5141520 Goble et al. Aug 1992 A
5147381 Heimerl et al. Sep 1992 A
5156609 Nakao et al. Oct 1992 A
5163343 Gish Nov 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5167643 Lynn Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171250 Yoon Dec 1992 A
5171259 Inoue Dec 1992 A
5176648 Holmes et al. Jan 1993 A
5192288 Thompson et al. Mar 1993 A
5192300 Fowler Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5192602 Spencer et al. Mar 1993 A
5193533 Body et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5207697 Carusillo et al. May 1993 A
5209756 Seedhom et al. May 1993 A
5217024 Dorsey et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5226908 Yoon Jul 1993 A
5236435 Sewell, Jr. Aug 1993 A
5242456 Nash et al. Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5242459 Buelna Sep 1993 A
5243857 Janota Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5250058 Miller et al. Oct 1993 A
5254105 Haaga Oct 1993 A
5255679 Imran Oct 1993 A
5269792 Kovac et al. Dec 1993 A
5275616 Fowler Jan 1994 A
5281422 Badylak et al. Jan 1994 A
5282808 Kovac et al. Feb 1994 A
5282827 Kensey et al. Feb 1994 A
5284488 Sideris Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290243 Chodorow et al. Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 Van Tassel et al. Mar 1994 A
5292332 Lee Mar 1994 A
5304183 Gourlay et al. Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304204 Bregen Apr 1994 A
5306254 Nash et al. Apr 1994 A
5309927 Welch May 1994 A
5318542 Hirsch et al. Jun 1994 A
5320639 Rudnick Jun 1994 A
5322694 Sixsmith Jun 1994 A
5327908 Gerry Jul 1994 A
5330445 Haaga Jul 1994 A
5330503 Yoon Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5334217 Das Aug 1994 A
5335680 Moore Aug 1994 A
5340360 Stefanchik Aug 1994 A
5342393 Stack Aug 1994 A
5344439 Otten Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354279 Hofling Oct 1994 A
5364406 Sewell, Jr. Nov 1994 A
5364408 Gordon Nov 1994 A
5366458 Korthoff et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5383896 Gershony et al. Jan 1995 A
5383897 Wholey Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5392978 Velez et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5413584 Schulze May 1995 A
5416584 Kay May 1995 A
5417699 Klein et al. May 1995 A
5419765 Weldon et al. May 1995 A
5419777 Hofling May 1995 A
5421832 Lefebvre Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5425489 Shichman et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431639 Shaw Jul 1995 A
5431667 Thompson et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437631 Janzen Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443481 Lee Aug 1995 A
5445167 Yoon et al. Aug 1995 A
5449359 Groiso Sep 1995 A
5451235 Lock et al. Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5462561 Voda Oct 1995 A
5464413 Siska, Jr. et al. Nov 1995 A
5464416 Steckel Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471982 Edwards et al. Dec 1995 A
5474557 Mai Dec 1995 A
5474569 Zinreich et al. Dec 1995 A
5476505 Limon Dec 1995 A
5478352 Fowler Dec 1995 A
5478353 Yoon Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5484420 Russo Jan 1996 A
5486195 Myers et al. Jan 1996 A
5496332 Sierra et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5510115 Breillatt, Jr. et al. Apr 1996 A
5522840 Krajicek Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5540716 Hlavacek Jul 1996 A
5544802 Crainich Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5547474 Kloeckl et al. Aug 1996 A
5560532 DeFonzo et al. Oct 1996 A
5571120 Yoon Nov 1996 A
5573784 Badylak et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5584879 Reimold et al. Dec 1996 A
5591205 Fowler Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5601602 Fowler Feb 1997 A
5609597 Lehrer Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5618291 Thompson et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5626614 Hart May 1997 A
5634936 Linden et al. Jun 1997 A
5643318 Tsukernik et al. Jul 1997 A
5645565 Rudd et al. Jul 1997 A
5645566 Brenneman et al. Jul 1997 A
5645567 Crainich Jul 1997 A
5649959 Hannam et al. Jul 1997 A
D383539 Croley Sep 1997 S
5674231 Green et al. Oct 1997 A
5676689 Kensey et al. Oct 1997 A
5676974 Valdes et al. Oct 1997 A
5681280 Rusk et al. Oct 1997 A
5681334 Evans et al. Oct 1997 A
5683405 Yacoubian et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5700273 Buelna et al. Dec 1997 A
5709224 Behl et al. Jan 1998 A
5715987 Kelley et al. Feb 1998 A
5716375 Fowler Feb 1998 A
5720755 Dakov Feb 1998 A
5725498 Janzen et al. Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728116 Rosenman Mar 1998 A
5728122 Leschinsky et al. Mar 1998 A
5728132 Van Tassel et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5735873 MacLean Apr 1998 A
5749826 Faulkner May 1998 A
5752966 Chang May 1998 A
5755726 Pratt et al. May 1998 A
5755727 Kontos May 1998 A
5755778 Kleshinski May 1998 A
5766217 Christy Jun 1998 A
5766246 Mulhauser et al. Jun 1998 A
5769870 Salahieh et al. Jun 1998 A
5776147 Dolendo Jul 1998 A
5779707 Bertholet et al. Jul 1998 A
5780807 Saunders Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5795958 Rao et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797933 Snow et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810776 Bacich et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810851 Yoon Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5827298 Hart et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5830217 Ryan Nov 1998 A
5830221 Stein et al. Nov 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5843164 Frantzen et al. Dec 1998 A
5843167 Dwyer et al. Dec 1998 A
5853421 Leschinsky et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855312 Toledano Jan 1999 A
5858082 Cruz et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5861043 Carn Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5868755 Kanner et al. Feb 1999 A
5868762 Cragg et al. Feb 1999 A
5868763 Spence et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873876 Christy Feb 1999 A
5873891 Sohn Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5891088 Thompson et al. Apr 1999 A
5897487 Ouchi Apr 1999 A
5902310 Foerster et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5904703 Gilson May 1999 A
5906631 Imran May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5908149 Welch et al. Jun 1999 A
5910155 Ratcliff et al. Jun 1999 A
5919207 Taheri Jul 1999 A
5922009 Epstein et al. Jul 1999 A
5928231 Klein et al. Jul 1999 A
5928251 Aranyi et al. Jul 1999 A
5928260 Chin et al. Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5948001 Larsen Sep 1999 A
5951518 Licata et al. Sep 1999 A
5951575 Bolduc et al. Sep 1999 A
5951576 Wakabayashi Sep 1999 A
5951589 Epstein et al. Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957900 Ouchi Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5957940 Tanner et al. Sep 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972023 Tanner et al. Oct 1999 A
5972034 Hofmann et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5976174 Ruiz Nov 1999 A
5984934 Ashby et al. Nov 1999 A
5984948 Hasson Nov 1999 A
5984949 Levin Nov 1999 A
5993468 Rygaard Nov 1999 A
5993476 Groiso Nov 1999 A
6001110 Adams Dec 1999 A
6004341 Zhu et al. Dec 1999 A
6007563 Nash et al. Dec 1999 A
6007574 Pulnev et al. Dec 1999 A
6010517 Baccaro Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015815 Mollison Jan 2000 A
6019779 Thorud et al. Feb 2000 A
6022372 Kontos Feb 2000 A
6024750 Mastri Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033427 Lee Mar 2000 A
6036703 Evans et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6045570 Epstein et al. Apr 2000 A
6048358 Barak Apr 2000 A
6056768 Cates et al. May 2000 A
6056769 Epstein et al. May 2000 A
6056770 Epstein et al. May 2000 A
6059800 Hart et al. May 2000 A
6059825 Hobbs et al. May 2000 A
6063085 Tay et al. May 2000 A
6063114 Nash et al. May 2000 A
6071300 Brenneman et al. Jun 2000 A
6074395 Trott et al. Jun 2000 A
6077281 Das Jun 2000 A
6077291 Das Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6080183 Tsugita et al. Jun 2000 A
6090130 Nash et al. Jul 2000 A
6102271 Longo et al. Aug 2000 A
6110184 Weadock Aug 2000 A
6113610 Poncet Sep 2000 A
6113611 Allen et al. Sep 2000 A
6113612 Swanson et al. Sep 2000 A
6117125 Rothbarth et al. Sep 2000 A
6117144 Nobles et al. Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6117157 Tekulve Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6120524 Taheri Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6146385 Torrie et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6149667 Hovland et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6165204 Levinson et al. Dec 2000 A
6171277 Ponzi Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6179849 Yencho et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6183775 Ventouras Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6206895 Levinson Mar 2001 B1
6206913 Yencho et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6210407 Webster Apr 2001 B1
6210418 Storz et al. Apr 2001 B1
6217554 Green Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6238705 Liu et al. May 2001 B1
6241740 Davis et al. Jun 2001 B1
6245079 Nobles et al. Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6254617 Spence et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6261309 Urbanski Jul 2001 B1
6267773 Gadberry et al. Jul 2001 B1
6273903 Wilk Aug 2001 B1
6277140 Ginn et al. Aug 2001 B2
6280460 Bolduc et al. Aug 2001 B1
6287322 Zhu et al. Sep 2001 B1
6287335 Drasler et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6296657 Brucker Oct 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6309416 Swanson et al. Oct 2001 B1
6319258 McAllen, III et al. Nov 2001 B1
6322580 Kanner Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6329386 Mollison Dec 2001 B1
6334865 Redmond et al. Jan 2002 B1
6348064 Kanner Feb 2002 B1
6355052 Neuss et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383208 Sancoff et al. May 2002 B1
6391048 Ginn et al. May 2002 B1
6395015 Borst et al. May 2002 B1
6398752 Sweezer et al. Jun 2002 B1
6402765 Monassevitch et al. Jun 2002 B1
6409739 Nobles et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6421899 Zitnay Jul 2002 B1
6423054 Ouchi Jul 2002 B1
6425911 Akerfeldt et al. Jul 2002 B1
6428472 Haas Aug 2002 B1
6428548 Durgin et al. Aug 2002 B1
6443158 Lafontaine et al. Sep 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450391 Kayan et al. Sep 2002 B1
6455053 Okada et al. Sep 2002 B1
6458130 Frazier et al. Oct 2002 B1
6461364 Ginn et al. Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488692 Spence et al. Dec 2002 B1
6494848 Sommercorn et al. Dec 2002 B1
6500115 Krattiger et al. Dec 2002 B2
6506210 Kanner Jan 2003 B1
6508828 Akerfeldt et al. Jan 2003 B1
6514280 Gilson Feb 2003 B1
6517555 Caro Feb 2003 B1
6517569 Mikus et al. Feb 2003 B2
6527737 Kaneshige Mar 2003 B2
6533762 Kanner et al. Mar 2003 B2
6533812 Swanson et al. Mar 2003 B2
6537288 Vargas et al. Mar 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6547806 Ding Apr 2003 B1
6551319 Lieberman Apr 2003 B2
6558349 Kirkman May 2003 B1
6569173 Blatter et al. May 2003 B1
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6582452 Coleman et al. Jun 2003 B2
6582482 Gillman et al. Jun 2003 B2
6596012 Akerfeldt et al. Jul 2003 B2
6596013 Yang et al. Jul 2003 B2
6599303 Peterson et al. Jul 2003 B1
6599311 Biggs et al. Jul 2003 B1
6602263 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613059 Schaller et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6620165 Wellisz Sep 2003 B2
6623509 Ginn Sep 2003 B2
6623510 Belef et al. Sep 2003 B2
6626918 Ginn et al. Sep 2003 B1
6626919 Swanstrom Sep 2003 B1
6626920 Whayne Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6632197 Lyon Oct 2003 B2
6632238 Ginn et al. Oct 2003 B2
6634537 Chen Oct 2003 B2
6645205 Ginn Nov 2003 B2
6645225 Atkinson Nov 2003 B1
6652538 Kayan et al. Nov 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663633 Pierson, III Dec 2003 B1
6663655 Ginn et al. Dec 2003 B2
6669714 Coleman et al. Dec 2003 B2
6673083 Kayan et al. Jan 2004 B1
6676665 Foley et al. Jan 2004 B2
6676671 Robertson et al. Jan 2004 B2
6676685 Pedros et al. Jan 2004 B2
6679904 Gleeson et al. Jan 2004 B2
6685707 Roman et al. Feb 2004 B2
6689147 Koster, Jr. Feb 2004 B1
6695867 Ginn et al. Feb 2004 B2
6699256 Logan et al. Mar 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6712837 Akerfeldt et al. Mar 2004 B2
6719777 Ginn et al. Apr 2004 B2
6726704 Loshakove et al. Apr 2004 B1
6743195 Zucker Jun 2004 B2
6743243 Roy et al. Jun 2004 B1
6743259 Ginn Jun 2004 B2
6746472 Frazier et al. Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755842 Kanner et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6776784 Ginn Aug 2004 B2
6780197 Roe et al. Aug 2004 B2
6786915 Akerfeldt et al. Sep 2004 B2
6790218 Jayaraman Sep 2004 B2
6790220 Morris et al. Sep 2004 B2
6837893 Miller Jan 2005 B2
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6890343 Ginn et al. May 2005 B2
6896687 Dakov May 2005 B2
6896692 Ginn et al. May 2005 B2
6913607 Ainsworth et al. Jul 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6926731 Coleman et al. Aug 2005 B2
6929634 Dorros et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6942691 Chuter Sep 2005 B1
6964668 Modesitt et al. Nov 2005 B2
6969391 Gazzani Nov 2005 B1
6969397 Ginn Nov 2005 B2
6989003 Wing et al. Jan 2006 B2
6989016 Tallarida et al. Jan 2006 B2
7001398 Carley et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7008435 Cummins Mar 2006 B2
7008439 Janzen et al. Mar 2006 B1
7025776 Houser et al. Apr 2006 B1
7033379 Peterson Apr 2006 B2
7060084 Loshakove et al. Jun 2006 B1
7063711 Loshakove et al. Jun 2006 B1
7074232 Kanner et al. Jul 2006 B2
7076305 Imran et al. Jul 2006 B2
7083635 Ginn Aug 2006 B2
7087064 Hyde Aug 2006 B1
7087088 Berg et al. Aug 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7112225 Ginn Sep 2006 B2
7144411 Ginn et al. Dec 2006 B2
7163551 Anthony et al. Jan 2007 B2
7169158 Sniffin et al. Jan 2007 B2
7169164 Borillo et al. Jan 2007 B2
7211101 Carley et May 2007 B2
7220268 Blatter May 2007 B2
7229452 Kayan Jun 2007 B2
7261716 Strobel et al. Aug 2007 B2
7306614 Weller et al. Dec 2007 B2
7311720 Mueller et al. Dec 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7316706 Bloom et al. Jan 2008 B2
7322995 Buckman et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
D566272 Walburg et al. Apr 2008 S
7361178 Hearn et al. Apr 2008 B2
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7393363 Ginn Jul 2008 B2
7396359 Derowe et al. Jul 2008 B1
7431729 Chanduszko Oct 2008 B2
7445596 Kucklick et al. Nov 2008 B2
7465286 Patterson et al. Dec 2008 B2
7533790 Knodel et al. May 2009 B1
7556632 Zadno Jul 2009 B2
7582103 Young et al. Sep 2009 B2
7582104 Corcoran et al. Sep 2009 B2
7597706 Kanner et al. Oct 2009 B2
7618427 Ortiz et al. Nov 2009 B2
7622628 Bergin et al. Nov 2009 B2
D611144 Reynolds et al. Mar 2010 S
7678135 Maahs et al. Mar 2010 B2
7780696 Daniel et al. Aug 2010 B2
7806904 Carley et al. Oct 2010 B2
7819895 Ginn et al. Oct 2010 B2
7824419 Boraiah Nov 2010 B2
7841502 Walberg et al. Nov 2010 B2
7842068 Ginn Nov 2010 B2
7850709 Cummins et al. Dec 2010 B2
7850710 Huss Dec 2010 B2
7850797 Carley et al. Dec 2010 B2
7854810 Carley et al. Dec 2010 B2
7857828 Jabba et al. Dec 2010 B2
7867249 Palermo et al. Jan 2011 B2
7875054 LaFontaine Jan 2011 B2
7879071 Carley et al. Feb 2011 B2
7887555 Carley et al. Feb 2011 B2
7887563 Cummins et al. Feb 2011 B2
7901428 Ginn et al. Mar 2011 B2
7905900 Palermo et al. Mar 2011 B2
7918873 Cummins et al. Apr 2011 B2
7931669 Ginn et al. Apr 2011 B2
7931671 Tenerz Apr 2011 B2
7967842 Bakos Jun 2011 B2
8007512 Ginn et al. Aug 2011 B2
8083768 Ginn et al. Dec 2011 B2
8103327 Harlev et al. Jan 2012 B2
8105352 Egnelöv Jan 2012 B2
8128644 Carley et al. Mar 2012 B2
8172749 Melsheimer May 2012 B2
8182497 Carley et al. May 2012 B2
8192459 Cummins et al. Jun 2012 B2
8202283 Carley et al. Jun 2012 B2
8202293 Ellingwood et al. Jun 2012 B2
8202294 Jabba et al. Jun 2012 B2
8211122 McIntosh Jul 2012 B2
8216260 Lam et al. Jul 2012 B2
8226681 Clark et al. Jul 2012 B2
8236026 Carley et al. Aug 2012 B2
8257390 Carley et al. Sep 2012 B2
8303624 Fortson Nov 2012 B2
8313497 Walberg et al. Nov 2012 B2
8323312 Clark Dec 2012 B2
8398656 Palermo et al. Mar 2013 B2
8398676 Roorda et al. Mar 2013 B2
8403929 Weisshaupt et al. Mar 2013 B2
8409228 Blatter et al. Apr 2013 B2
8469995 Cummins et al. Jun 2013 B2
8480687 Ducharme et al. Jul 2013 B2
8486092 Carley et al. Jul 2013 B2
8486108 Carley et al. Jul 2013 B2
8518057 Walberg et al. Aug 2013 B2
8529587 Ellingwood et al. Sep 2013 B2
8556930 Ellingwood Oct 2013 B2
8556932 Ziobro Oct 2013 B2
8562630 Campbell Oct 2013 B2
8574244 Reynolds Nov 2013 B2
8579932 Pantages Nov 2013 B2
8585836 Carley et al. Nov 2013 B2
8590760 Cummins et al. Nov 2013 B2
8597325 Ginn Dec 2013 B2
8603116 Roorda Dec 2013 B2
8603136 Ginn Dec 2013 B2
8617184 Oepen Dec 2013 B2
8657852 Roorda et al. Feb 2014 B2
8672953 Reyes et al. Mar 2014 B2
8690910 Carley et al. Apr 2014 B2
8728119 Cummins May 2014 B2
8834494 Schorr et al. Sep 2014 B2
8992549 Bennett, III Mar 2015 B2
20010007077 Ginn et al. Jul 2001 A1
20010021855 Levinson Sep 2001 A1
20010031972 Robertson et al. Oct 2001 A1
20010031973 Nobles et al. Oct 2001 A1
20010044639 Levinson Nov 2001 A1
20010046518 Sawhney Nov 2001 A1
20010047180 Grudem et al. Nov 2001 A1
20020022822 Cragg et al. Feb 2002 A1
20020026215 Redmond et al. Feb 2002 A1
20020026216 Grimes Feb 2002 A1
20020029050 Gifford, III et al. Mar 2002 A1
20020038127 Blatter et al. Mar 2002 A1
20020042622 Vargas et al. Apr 2002 A1
20020049427 Wiener et al. Apr 2002 A1
20020049453 Nobles et al. Apr 2002 A1
20020056460 Boyd et al. May 2002 A1
20020058960 Hudson et al. May 2002 A1
20020062104 Ashby et al. May 2002 A1
20020077656 Ginn et al. Jun 2002 A1
20020077657 Ginn et al. Jun 2002 A1
20020077658 Ginn Jun 2002 A1
20020082641 Ginn et al. Jun 2002 A1
20020095164 Andreas et al. Jul 2002 A1
20020095181 Beyar Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020107542 Kanner et al. Aug 2002 A1
20020151921 Kanner et al. Oct 2002 A1
20020151963 Brown et al. Oct 2002 A1
20020169475 Gainor et al. Nov 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020198562 Akerfeldt et al. Dec 2002 A1
20020198589 Leong Dec 2002 A1
20030004543 Gleeson et al. Jan 2003 A1
20030009180 Hinchliffe et al. Jan 2003 A1
20030018358 Saadat Jan 2003 A1
20030023248 Parodi Jan 2003 A1
20030032981 Kanner et al. Feb 2003 A1
20030033006 Phillips et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030055455 Yang et al. Mar 2003 A1
20030060846 Egnelov et al. Mar 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030083679 Grudem et al. May 2003 A1
20030093096 McGuckin et al. May 2003 A1
20030093108 Avellanet et al. May 2003 A1
20030097140 Kanner May 2003 A1
20030109890 Kanner et al. Jun 2003 A1
20030125766 Ding Jul 2003 A1
20030139819 Beer et al. Jul 2003 A1
20030144695 McGuckin, Jr. et al. Jul 2003 A1
20030158578 Pantages et al. Aug 2003 A1
20030167063 Kerr Sep 2003 A1
20030195504 Tallarida et al. Oct 2003 A1
20030208211 Kortenbach Nov 2003 A1
20040002763 Phillips et al. Jan 2004 A1
20040009205 Sawhney Jan 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040059376 Breuniger Mar 2004 A1
20040068273 Fariss et al. Apr 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040082906 Tallarida et al. Apr 2004 A1
20040087985 Loshakove et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040092964 Modesitt et al. May 2004 A1
20040092968 Caro et al. May 2004 A1
20040092973 Chanduszko et al. May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040097978 Modesitt et al. May 2004 A1
20040106980 Solovay et al. Jun 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040143291 Corcoran et al. Jul 2004 A1
20040147957 Pierson, III Jul 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040158309 Wachter et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040225301 Roop et al. Nov 2004 A1
20040243216 Gregorich Dec 2004 A1
20040249412 Snow et al. Dec 2004 A1
20040254591 Kanner et al. Dec 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20040267312 Kanner et al. Dec 2004 A1
20050038460 Jayaraman Feb 2005 A1
20050038500 Boylan et al. Feb 2005 A1
20050059982 Zung et al. Mar 2005 A1
20050075654 Kelleher Apr 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050090859 Ravlkumar Apr 2005 A1
20050119695 Carley et al. Jun 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050148818 Mesallum Jul 2005 A1
20050149066 Stafford Jul 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050152949 Hotchkiss et al. Jul 2005 A1
20050154401 Weldon et al. Jul 2005 A1
20050165357 McGuckin et al. Jul 2005 A1
20050169974 Tenerz et al. Aug 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050187564 Jayaraman Aug 2005 A1
20050203552 Laufer et al. Sep 2005 A1
20050216057 Coleman et al. Sep 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050228405 Maruyama et al. Oct 2005 A1
20050228443 Yassinzadeh Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267524 Chanduszko Dec 2005 A1
20050273136 Belef et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060030867 Zadno Feb 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060069397 Nobles et al. Mar 2006 A1
20060100664 Pai et al. May 2006 A1
20060142784 Kontos Jun 2006 A1
20060190014 Ginn et al. Aug 2006 A1
20060190036 Wendel et al. Aug 2006 A1
20060190037 Ginn et al. Aug 2006 A1
20060195123 Ginn et al. Aug 2006 A1
20060195124 Ginn et al. Aug 2006 A1
20060195125 Sakakine et al. Aug 2006 A1
20060206146 Tenerz Sep 2006 A1
20060217744 Bender et al. Sep 2006 A1
20060229553 Hammack et al. Oct 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20060281968 Duran et al. Dec 2006 A1
20060287673 Brett et al. Dec 2006 A1
20060287674 Ginn et al. Dec 2006 A1
20060293698 Douk Dec 2006 A1
20070005093 Cox Jan 2007 A1
20070010851 Chanduszko et al. Jan 2007 A1
20070010853 Ginn et al. Jan 2007 A1
20070021778 Carly Jan 2007 A1
20070027476 Harris et al. Feb 2007 A1
20070027525 Ben-Muvhar Feb 2007 A1
20070049968 Sibbitt, Jr. et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070060858 Sogard et al. Mar 2007 A1
20070060895 Sibbitt, Jr. et al. Mar 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070073337 Abbott et al. Mar 2007 A1
20070078302 Ortiz et al. Apr 2007 A1
20070083230 Javois Apr 2007 A1
20070083231 Lee Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070112304 Voss May 2007 A1
20070112365 Hilal et al. May 2007 A1
20070112385 Conlon May 2007 A1
20070123816 Zhu et al. May 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070149996 Coughlin Jun 2007 A1
20070167981 Opolski et al. Jul 2007 A1
20070172430 Brito et al. Jul 2007 A1
20070179527 Eskuri et al. Aug 2007 A1
20070185529 Coleman et al. Aug 2007 A1
20070185530 Chin-Chen et al. Aug 2007 A1
20070203507 McLaughlin et al. Aug 2007 A1
20070225755 Preinitz et al. Sep 2007 A1
20070225756 Preinitz et al. Sep 2007 A1
20070225757 Preinitz et al. Sep 2007 A1
20070225758 Preinitz et al. Sep 2007 A1
20070239209 Fallman Oct 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070265658 Nelson et al. Nov 2007 A1
20070275036 Green, III et al. Nov 2007 A1
20070276488 Wachter et al. Nov 2007 A1
20070282373 Ashby et al. Dec 2007 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080033459 Shafi et al. Feb 2008 A1
20080045979 Ma Feb 2008 A1
20080058839 Nobles et al. Mar 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080082123 Forsberg et al. Apr 2008 A1
20080086075 Isik et al. Apr 2008 A1
20080091235 Sirota Apr 2008 A1
20080093414 Bender et al. Apr 2008 A1
20080097509 Beyar et al. Apr 2008 A1
20080114378 Matsushita May 2008 A1
20080114395 Mathisen et al. May 2008 A1
20080177288 Carlson Jul 2008 A1
20080208225 Seibold et al. Aug 2008 A1
20080210737 Ginn et al. Sep 2008 A1
20080215089 Williams et al. Sep 2008 A1
20080215090 Gonzales et al. Sep 2008 A1
20080221616 Ginn et al. Sep 2008 A1
20080243148 Mikkaichi et al. Oct 2008 A1
20080243182 Bates et al. Oct 2008 A1
20080249504 Lattouf et al. Oct 2008 A1
20080269801 Coleman et al. Oct 2008 A1
20080269802 Coleman et al. Oct 2008 A1
20080272173 Coleman et al. Nov 2008 A1
20080287988 Smith et al. Nov 2008 A1
20080294001 Surti Nov 2008 A1
20080300628 Ellingwood Dec 2008 A1
20080312667 Drasler et al. Dec 2008 A1
20080312686 Ellingwood Dec 2008 A1
20080312740 Wachter et al. Dec 2008 A1
20090054912 Heanue et al. Feb 2009 A1
20090062846 Ken Mar 2009 A1
20090112306 Bonsignore et al. Apr 2009 A1
20090132031 Cook et al. May 2009 A1
20090137900 Bonner et al. May 2009 A1
20090157101 Reyes et al. Jun 2009 A1
20090157102 Reynolds et al. Jun 2009 A1
20090171388 Dave et al. Jul 2009 A1
20090187215 Mackiewicz et al. Jul 2009 A1
20090216267 Willard et al. Aug 2009 A1
20090221960 Albrecht et al. Sep 2009 A1
20090227938 Fasching et al. Sep 2009 A1
20090230168 Coleman et al. Sep 2009 A1
20090254119 Sibbitt, Jr. et al. Oct 2009 A1
20090259233 Bogart et al. Oct 2009 A1
20090281555 Stone Nov 2009 A1
20090287244 Kokish Nov 2009 A1
20090299133 Gifford, III et al. Dec 2009 A1
20090312789 Kassab et al. Dec 2009 A1
20100022821 Dubi et al. Jan 2010 A1
20100042118 Garrison et al. Feb 2010 A1
20100042144 Bennett Feb 2010 A1
20100114156 Mehl May 2010 A1
20100130965 Sibbitt, Jr. et al. May 2010 A1
20100168790 Clark Jul 2010 A1
20100179567 Voss et al. Jul 2010 A1
20100179571 Voss Jul 2010 A1
20100179572 Voss et al. Jul 2010 A1
20100179589 Roorda et al. Jul 2010 A1
20100179590 Fortson et al. Jul 2010 A1
20100185216 Garrison et al. Jul 2010 A1
20100185234 Fortson et al. Jul 2010 A1
20100217132 Ellingwood et al. Aug 2010 A1
20100249828 Mavani et al. Sep 2010 A1
20110054492 Clark Mar 2011 A1
20110066164 Walberg et al. Mar 2011 A1
20110082495 Ruiz Apr 2011 A1
20110106148 Ginn et al. May 2011 A1
20110137340 Cummins Jun 2011 A1
20110166584 Palermo et al. Jul 2011 A1
20110178548 Tenerz Jul 2011 A1
20110190793 Nobles et al. Aug 2011 A1
20110218568 Voss Sep 2011 A1
20110270282 Lemke Nov 2011 A1
20110288563 Gianotti et al. Nov 2011 A1
20110313452 Carley et al. Dec 2011 A1
20120029555 Fortson et al. Feb 2012 A1
20120101520 Ginn et al. Apr 2012 A1
20120143216 Voss Jun 2012 A1
20120245623 Kariniemi et al. Sep 2012 A1
20130053792 Fischell et al. Feb 2013 A1
20130138144 Yribarren May 2013 A1
20130190778 Palermo Jul 2013 A1
20130253539 Walberg et al. Sep 2013 A1
20130310853 Zaugg et al. Nov 2013 A1
20130338708 Cummins et al. Dec 2013 A1
20140005692 Ellingwood et al. Jan 2014 A1
20140018850 Ellingwood Jan 2014 A1
20140081318 Houser et al. Mar 2014 A1
20140142624 Pantages et al. May 2014 A1
20140180311 Voss Jun 2014 A1
20140309686 Ginn et al. Oct 2014 A1
20140364903 Roorda et al. Dec 2014 A1
20150073471 Clark Mar 2015 A1
20150190071 Ellingwood et al. Jul 2015 A1
20150265279 Walberg et al. Sep 2015 A1
Foreign Referenced Citations (138)
Number Date Country
2003297432 Jul 2004 AU
2 339 060 Feb 2000 CA
197 11 288 Oct 1998 DE
29723736 Apr 1999 DE
19859952 Feb 2000 DE
102006056283 Jun 2008 DE
0 386 361 Sep 1990 EP
0 534 696 Mar 1993 EP
0 621 032 Oct 1994 EP
0 756 851 Feb 1997 EP
0 774 237 May 1997 EP
0 858 776 Aug 1998 EP
0 941 697 Sep 1999 EP
1 867 287 Dec 2007 EP
2 443 238 Jul 1980 FR
2 715 290 Jul 1995 FR
2 722 975 Feb 1996 FR
2 768 324 Mar 1999 FR
1 358 466 Jul 1974 GB
2 075 144 Nov 1981 GB
2 397 240 Jul 2004 GB
S20000722 Oct 2001 IE
S20000724 Oct 2001 IE
S20010547 Jul 2002 IE
S20010815 Jul 2002 IE
S20010748 Aug 2002 IE
S20010749 Aug 2002 IE
S20020452 Dec 2002 IE
S20020664 Feb 2003 IE
S20020665 Feb 2003 IE
S20020451 Jul 2003 IE
S20020552 Jul 2003 IE
S20030424 Dec 2003 IE
S20030490 Jan 2004 IE
S20040368 Nov 2005 IE
S20050342 Nov 2005 IE
58-181006 Dec 1983 JP
12 74750 Nov 1989 JP
2000102546 Apr 2000 JP
9302140 Jul 1995 NL
171425 Apr 1997 PL
2086192 Aug 1997 RU
495067 Dec 1975 SU
912155 Mar 1982 SU
1243708 Jul 1986 SU
1324650 Jul 1987 SU
1405828 Jun 1988 SU
1456109 Feb 1989 SU
1560133 Apr 1990 SU
WO 9624291 Aug 1996 WO
WO 9700046 Jan 1997 WO
WO 9707741 Mar 1997 WO
WO 9720505 Jun 1997 WO
WO 9727897 Aug 1997 WO
WO 9806346 Feb 1998 WO
WO 9806448 Feb 1998 WO
WO 9816161 Apr 1998 WO
WO 9817179 Apr 1998 WO
WO 9818389 May 1998 WO
WO 9824374 Jun 1998 WO
WO 9825508 Jun 1998 WO
WO 9858591 Dec 1998 WO
WO 9921491 May 1999 WO
WO 9940849 Aug 1999 WO
WO 9960941 Dec 1999 WO
WO 9962408 Dec 1999 WO
WO 9962415 Dec 1999 WO
WO 0006029 Feb 2000 WO
WO 0007505 Feb 2000 WO
WO 0007640 Feb 2000 WO
WO 0027311 May 2000 WO
WO 0027313 May 2000 WO
WO 0056223 Sep 2000 WO
WO 0056227 Sep 2000 WO
WO 0056228 Sep 2000 WO
WO 0071032 Nov 2000 WO
WO 0121058 Mar 2001 WO
WO 0135832 May 2001 WO
WO 0147594 Jul 2001 WO
WO 0149186 Jul 2001 WO
WO 0191628 Dec 2001 WO
WO 0219915 Mar 2002 WO
WO 0219920 Mar 2002 WO
WO 0219922 Mar 2002 WO
WO 0219924 Mar 2002 WO
WO 0228286 Apr 2002 WO
WO 0238055 May 2002 WO
WO 0245593 Jun 2002 WO
WO 0245594 Jun 2002 WO
WO 02062234 Aug 2002 WO
WO 02098302 Dec 2002 WO
WO 03013363 Feb 2003 WO
WO 03013364 Feb 2003 WO
WO 03047434 Jun 2003 WO
WO 03071955 Sep 2003 WO
WO 03071956 Sep 2003 WO
WO 03071957 Sep 2003 WO
WO 03094748 Nov 2003 WO
WO 03101310 Dec 2003 WO
WO 2004004578 Jan 2004 WO
WO 2004012602 Feb 2004 WO
WO 2004060169 Jul 2004 WO
WO 2004069054 Aug 2004 WO
WO 2005000126 Jan 2005 WO
WO 2005006990 Jan 2005 WO
WO 2005041782 May 2005 WO
WO 2005063129 Jul 2005 WO
WO 2005082256 Sep 2005 WO
WO 2005092204 Oct 2005 WO
WO 2005110240 Nov 2005 WO
WO 2005112782 Dec 2005 WO
WO 2005115251 Dec 2005 WO
WO 2005115521 Dec 2005 WO
WO 2006000514 Jan 2006 WO
WO 2006026116 Mar 2006 WO
WO 2006052611 May 2006 WO
WO 2006052612 May 2006 WO
WO 2006078578 Jul 2006 WO
WO 2006083889 Aug 2006 WO
WO 2006115901 Nov 2006 WO
WO 2006115904 Nov 2006 WO
WO 2006118877 Nov 2006 WO
WO 2007005585 Jan 2007 WO
WO 2007025014 Mar 2007 WO
WO 2007081836 Jul 2007 WO
WO 2007088069 Aug 2007 WO
WO 2008031102 Mar 2008 WO
WO 2008036384 Mar 2008 WO
WO 2008074027 Jun 2008 WO
WO 2008150915 Dec 2008 WO
WO 2009079091 Jun 2009 WO
WO 2010062693 Jun 2010 WO
WO 2010081101 Jul 2010 WO
WO 2010081102 Jul 2010 WO
WO 2010081103 Jul 2010 WO
WO 2010081106 Jul 2010 WO
200100527 Jan 2001 ZA
200100528 Jan 2001 ZA
Non-Patent Literature Citations (632)
Entry
U.S. Appl. No. 09/610,128, filed Jul. 5, 2000, Kerievsky.
U.S. Appl. No. 09/866,551, filed May 25, 2001, Ginn.
U.S. Appl. No. 12/113,092, filed Apr. 30, 2008, Ginn et al.
U.S. Appl. No. 13/017,636, filed Jan. 31, 2011, Carley et al.
U.S. Appl. No. 60/693,531, filed Jun. 24, 2005, Carly.
U.S. Appl. No. 60/696,069, filed Jul. 1, 2005, Pantages et al.
U.S. Appl. No. 60/793,444, filed Apr. 20, 2006, Jones et al.
U.S. Appl. No. 60/946,026, filed Jun. 25, 2007, Ellingwood.
U.S. Appl. No. 60/946,030, filed Jun. 25, 2007, Voss et al.
U.S. Appl. No. 60/946,042, filed Jun. 25, 2007, Ellingwood et al.
U.S. Appl. No. 61/015,144, filed Dec. 19, 2007, Mackiewicz et al.
U.S. Appl. No. 61/109,822, filed Oct. 30, 2008, Mehl et al.
U.S. Appl. No. 61/139,995, filed Dec. 22, 2008, Clark.
U.S. Appl. No. 61/141,597, filed Dec. 30, 2008, Clark.
U.S. Appl. No. 61/143,748, filed Jan. 9, 2009, Mehl et al.
U.S. Appl. No. 61/143,751, filed Jan. 9, 2009, Voss et al.
U.S. Appl. No. 61/145,468, filed Jan. 16, 2009, Fortson, et al.
U.S. Appl. No. 14/246,926, filed Apr. 1, 2014, Carley et al.
U.S. Appl. No. 14/246,973, filed Apr. 1, 2014, Carley et al.
“Hand tool for forming telephone connections—comprises pliers with reciprocably driven ram crimping clip around conductors against anvil”, Derwent-ACC-No. 1978-B8090A. (Jan. 10, 1978).
Database WPI; Section PQ, Week 200120; Derwent Publications Ltd., London GB; Class P31, AN 2001-203165; XP002199926 & ZA 200 100 528 A (Anthony T), Feb. 28, 2001 abstract.
Deepak Mital et al, Renal Transplantation Without Sutures Using the Vascular Clipping System for Renal Artery and Vein Anastomosis—A New Technique, Transplantation Issue, Oct. 1996, pp. 1171-1173, vol. 62—No. 8, Section of Transplantation Surgery, Department of General Surgery, Rush-Presbyterian/St. Luke's Medical Center, Chigago, IL.
DL Wessel et al, Outpatient closure of the patent ductus arteriosus, Circulation, May 1988, pp. 1068-1071, vol. 77—No. 5, Department of Anesthesia, Children's Hospital, Boston, MA.
E Pikoulis et al, Arterial reconstruction with vascular clips is safe and quicker than sutured repair, Cardiovascular Surgery, Dec. 1998, pp. 573-578(6), vol. 6—No. 6, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD.
G Gershony et al, Novel vascular sealing device for closure of percutaneous vascular access sites, Cathet. Cardiovasc. Diagn., Jan. 1998, pp. 82-88, vol. 45.
H De Swart et al, A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites, American journal of cardiology, Aug. 1993, pp. 445-449, vol. 72—No. 5, Department of Cardiology, Academic Hospital Maastricht, The Netherlands.
Harrith M. Hasson M.D. , Laparoscopic Cannula Cone with Means for Cannula Stabilization and Wound Closure, The Journal of the American Association of Gynecologic Laparoscopists, May 1998, pp. 183-185, vol. 5—No. 2, Division of Obstetrics and Gynecology, University of Chicago, Chigago, IL.
J. Findlay et al, Carotid Arteriotomy Closure Using a Vascular Clip System, Neurosurgery, Mar. 1998, pp. 550-554, vol. 42—No. 3, Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Jeremy L Gilbert PhD, Wound Closure Biomaterials and Devices, Shock., Mar. 1999, p. 226, vol. 11—No. 3, Institution Northwestern University (editorial review).
Jochen T. Cremer, MD, et al, Different approaches for minimally invasive closure of atrial septal defects, Ann. Thorac. Surg., Nov. 1998, pp. 1648-1652, vol. 67, a Division of Thoracic and Cardiovascular Surgery, Surgical Center, Hannover Medical School. Hannover, Germany.
K Narayanan et al, Simultaneous primary closure of four fasciotomy wounds in a single setting using the Sure-Closure device, Injury, Jul. 1996, pp. 449-451, vol. 27—No. 6, Department of Surgery, Mercy Hospital of Pittsburgh, PA.
Marshall A.C., Lock J.E., Structural and Compliant Anatomy of the Patent Foramen Ovale in Patients Undergoing Transcatheter Closure, Am Heart J Aug. 2000; 140(2); pp. 303-307.
MD Gonze et al, Complications associated with percutaneous closure devices, Conference: Annual Meeting of the Society for Clinical Vascular Surgery, The American journal of surgery, Mar. 1999, pp. 209-211, vol. 178, No. 3, Department of Surgery, Section of Vascular Surgery, Ochsner Medical Institutions, New Orleans, LA.
MD Hellinger et al, Effective peritoneal and fascial closure of abdominal trocar sites utilizing the Endo-Judge, J Laparoendosc Surg., Oct. 1996, pp. 329-332, vol. 6—No. 5, Orlando Regional Medical Center, FL.
Michael Gianturco, A Play on Catheterization, Forbes, Dec. 1996, p. 146, vol. 158—No. 15.
Inlet Medical Inc. Brochure, pp. 1-2, referencing OM Elashry et al, Comparative clinical study of port-closure techniques following laparoscopic surgery, Department of Surgery, Mallickrodt Institute of Radiography, J Am Coll Surg., Oct. 1996, pp. 335-344, vol. 183—No. 4.
P M N Werker, et al, Review of facilitated approaches to vascular anastomosis surgery, Conference: Utrecht MICABG Workshop 2, The Annals of thoracic surgery, Apr. 1996, pp. S122-127, vol. 63—No. 6, Department of Plastic, Reconstructive and Hand surgery, University Hospital Utrecht Netherlands Departments of Cardiology and Cardiopulmonary Surgery, Heart Lung Institute, Utrecht Netherlands.; Utrect University Hospital Utrecht Netherlands.
Peter Rhee MD et al, Use of Titanium Vascular Staples in Trauma, Journal of Trauma-Injury Infection & Critical Care, Dec. 1998, pp. 1097-1099, vol. 45—No. 6, Institution from the Department of Surgery, Washington Hospital Center, Washington DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
ProstarXL—Percutaneous Vascular Surgical Device, www.Archive.org, Jun. 1998, Original Publisher: http://prostar.com, may also be found at http://web.archive.org/web/19980630040429/www.perclose.com/html/prstrxl.html.
SA Beyer-Enke et al, Immediate sealing of arterial puncture site following femoropopliteal angioplasty: A prospective randomized trial, Cardiovascular and Interventional Radiology 1996, Nov.-Dec. 1996, pp. 406-410, vol. 19—No. 6, Gen Hosp North, Dept Dianost & Intervent Radio!, Nurnberg, Germany (Reprint).
Scott Hensley, Closing Wounds. New Devices seal arterial punctures in double time, Modern Healthcare (United States), Mar. 23, 2008, p. 48.
Sigmund Silber et al, A novel vascular device for closure of percutaneous arterial access sites, The American Journal of Cardiology, Apr. 1999, pp. 1248-1252, vol. 83—No. 8.
Simonetta Blengino et al, A Randomized Study of the 8 French Hemostatic Puncture Closure Device vs Manual Compression After Coronary Interventions, Journal of the American College of Cardiology, Feb. 1995, p. 262A, vol. 25.—No. 2, Supplement 1.
Stretch Comb by Scunci, retrieved via internet at www.scunci.com/productdetail by examiner on Oct. 9, 2007, publication date unavailable.
Swee Lian Tan, MD, PhD, FACS, Explanation of Infected Hemostatic Puncture Closure Devices—A Case Report, Vascular and Endovascular Surgery, 1999, pp. 507-510, vol. 33—No. 5, Parkland Medical Center, Derry, New Hampshire.
SY Nakada et al, Comparison of newer laparoscopic port closure techniques in the porcine model, J Endourol, Oct. 1995, pp. 397-401, vol. 9—No. 5, Department of Surgery/Urology, University of Wisconsin Medical School, Madison.
Taber's Cyclopedic Medical Dictionary, 18th Ed. 1997, pp. 747 and 1420.
Thomas P. Baum RPA-C et al, Delayed Primary Closure Using Silastic Vessel Loops and Skin Staples: Description of the Technique and Case Reports, Annals of Plastic Surgery, Mar. 1999, pp. 337-340, vol. 42—No. 3, Institution Department of Plastic and Reconstructive Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
Tomoaki Hinohara, Percutaneous vascular surgery (Prostar® Plus and Techstar® for femoral artery site closure), Interventional Cardiology Newsletter, May-Jul. 1997, pp. 19-22, pp. 24-28, vol. 5—No. 3-4.
UT Aker et al, Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device, Cathet Cardiovasc Diagn, Mar. 1994, pp. 228-232, vol. 33—No. 3, Missouri Baptist Medical Center, St. Louis.
Wei Qu et al, An absorbable pinned-ring device for microvascular anastomosis of vein grafts: Experimental studies, Microsurgery 1999, Mar. 1999, pp. 128-134, vol. 19—No. 3, Department of Orthopaedic Surgery, Hiroshima University School of Medicine, Hiroshima, Japan.
William G. Kussmaul III MD, et al., Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device, Journal of the American College of Cardiology, Jun. 1995, pp. 1685-1692, vol. 25—No. 7.
U.S. Appl. No. 09/478,179, Nov. 6, 2000, Notice of Allowance.
U.S. Appl. No. 09/546,998 May 6, 2002, Notice of Allowance.
U.S. Appl. No. 09/610,238, Mar. 26, 2001, Notice of Allowance.
U.S. Appl. No. 09/610,238, Sep. 5, 2001, Office Action.
U.S. Appl. No. 09/610,238, Feb. 11, 2002, Notice of Allowance.
U.S. Appl. No. 09/680,837, Jul. 9, 2002, Office Action.
U.S. Appl. No. 09/680,837, Nov. 6, 2002, Office Action.
U.S. Appl. No. 09/680,837, Mar. 25, 2003, Office Action.
U.S. Appl. No. 09/680,837, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,178, Aug. 1, 2002, Office Action.
U.S. Appl. No. 09/732,178, Dec. 24, 2002, Office Action.
U.S. Appl. No. 09/732,178, Jun. 10, 2003, Office Action.
U.S. Appl. No. 09/732,178, Jul. 3, 2003, Office Action.
U.S. Appl. No. 09/732,178, Nov. 17, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,835, Sep. 11, 2003, Office Action.
U.S. Appl. No. 09/732,835, Feb. 9, 2004, Office Action.
U.S. Appl. No. 09/732,835, Mar. 17, 2004, Notice of Allowance.
U.S. Appl. No. 09/764,813, Mar. 26, 2001, Office Action.
U.S. Appl. No. 09/764,813, Jun. 4, 2001, Notice of Allowance.
U.S. Appl. No. 09/933,299, Feb. 26, 2003, Office Action.
U.S. Appl. No. 09/933,299, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/948,813, Jan. 31, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,398, Mar. 4, 2003, Office Action.
U.S. Appl. No. 09/949,398, Jul. 28, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,438, Dec. 17, 2002, Office Action.
U.S. Appl. No. 09/949,438, Apr. 21, 2003, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 27, 2004, Office Action.
U.S. Appl. No. 10/006,400, Feb. 23, 2005, Office Action.
U.S. Appl. No. 10/006,400, Apr. 11, 2005, Office Action.
U.S. Appl. No. 10/006,400, Jul. 27, 2005, Office Action.
U.S. Appl. No. 10/006400, Mar. 6, 2006, Office Action.
U.S. Appl. No. 10/006,400, May 24, 2006, Office Action.
U.S. Appl. No. 10/006,400, Oct. 26, 2006, Office Action.
U.S. Appl. No. 10/006,400, Apr. 19, 2007, Office Action.
U.S. Appl. No. 10/006,400, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/006,400, Jan. 2, 2009, Office Action.
U.S. Appl. No. 10/006,400, Jul. 9, 2009, Notice of Allowance.
U.S. Appl. No. 10/006,400, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Apr. 27, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/081,717, Sep. 29, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,723, Sep. 29, 2004, Office Action.
U.S. Appl. No. 10/081,723, May 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/081,725, Feb. 9, 2004, Notice of Allowance.
U.S. Appl. No. 10/081,725, Apr. 13, 2004, Office Action.
U.S. Appl. No. 10/081,726, Apr. 11, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,726, Jun. 9, 2003, Notice of Allowance.
U.S. Appl. No. 10/147,774, Nov. 4, 2004, Office Action.
U.S. Appl. No. 10/147,774, May 4, 2005, Office Action.
U.S. Appl. No. 10/147,774, Oct. 18, 2005, Office Action.
U.S. Appl. No. 10/147,774, Apr. 18, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Sep. 27, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/147,774, Jun. 30, 2008, Office Action.
U.S. Appl. No. 10/147,774, Mar. 18, 2009, Office Action.
U.S. Appl. No. 10/147,774, Oct. 26, 2009, Office Action.
U.S. Appl. No. 10/147,774, Jun. 8, 2010, Office Action.
U.S. Appl. No. 10/147,774, Dec. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/240,183, Jul. 27, 2004, Office Action.
U.S. Appl. No. 10/240,183, Dec. 17, 2004, Office Action.
U.S. Appl. No. 10/240,183, Mar. 9, 2005, Notice of Allowance.
U.S. Appl. No. 10/240,183, Aug. 11, 2006, Office Action.
U.S. Appl. No. 10/264,306, Feb. 9, 2005, Office Action.
U.S. Appl. No. 10/264,306, Oct. 4, 2005, Office Action.
U.S. Appl. No. 10/264,306, May 10, 2006, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jul. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/264,306, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jun. 27, 2008, Office Action.
U.S. Appl. No. 10/264,306, Feb. 26, 2009, Office Action.
U.S. Appl. No. 10/264,306, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/264,306, Jan. 27, 2010, Office Action.
U.S. Appl. No. 10/264,306, Jun. 15, 2010, Office Action.
U.S. Appl. No. 10/264,306, Oct. 29, 2010, Notice of Allowance.
U.S. Appl. No. 10/335,075, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/335,075, Dec. 19, 2005, Office Action.
U.S. Appl. No. 10/335,075, Apr. 21, 2006, Office Action.
U.S. Appl. No. 10/335,075, Dec. 27, 2006, Notice of Allowance.
U.S. Appl. No. 10/356,214, Nov. 30, 2005, Office Action.
U.S. Appl. No. 10/356,214 ,Aug. 23, 2006, Office Action.
U.S. Appl. No. 10/356,214, Feb. 13, 2007, Office Action.
U.S. Appl. No. 10/356,214, Sep. 12, 2007, Office Action.
U.S. Appl. No. 10/356,214, Mar. 6, 2008, Office Action.
U.S. Appl. No. 10/356,214, Nov. 4, 2008, Office Action.
U.S. Appl. No. 10/356,214, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/356,214, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, May 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, Sep. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 10, 2004, Office Action.
U.S. Appl. No. 10/435,104, Sep. 21, 2004, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 3, 2006, Examiner's Amendment.
U.S. Appl. No. 10/435,104, May 16, 2006, Office Action.
U.S. Appl. No. 10/435,104, Dec. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 10, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Aug. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Oct. 26, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Nov. 14, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Apr. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Sep. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Dec. 22, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 23, 2009, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 2, 2010, Office Action.
U.S. Appl. No. 10/435,104, Oct. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/455,768, Nov. 16, 2004, Office Action.
U.S. Appl. No. 10/455,768, Apr. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/486,067, Jan. 10, 2006, Office Action.
U.S. Appl. No. 10/486,067, Sep. 20, 2006, Notice of Allowance.
U.S. Appl. No. 10/486,070, Apr. 20, 2005, Office Action.
U.S. Appl. No. 10/486,070, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/486,070, Oct. 18, 2005, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 13, 2007, Office Action.
U.S. Appl. No. 10/517,004, Jan. 30, 2008, Office Action.
U.S. Appl. No. 10/517,004, Aug. 13, 2008, Notice of Allowance.
U.S. Appl. No. 10/517,004, Feb. 10, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Mar. 24, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jun. 26, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Apr. 23, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/519,778, Feb. 23, 2006, Office Action.
U.S. Appl. No. 10/519,778, May 31, 2006, Notice of Allowance.
U.S. Appl. No. 10/541,083, Oct. 16, 2007, Office Action.
U.S. Appl. No. 10/541,083, Oct. 31, 2007, Office Action.
U.S. Appl. No. 10/541,083, May 5, 2008, Office Action.
U.S. Appl. No. 10/541,083, Sep. 19, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Dec. 29, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Apr. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Sep. 30, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Feb. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, May 10, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Aug. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Jun. 30, 2006, Office Action.
U.S. Appl. No. 10/616,832, Oct. 20, 2006, Office Action.
U.S. Appl. No. 10/616,832, May 29, 2007, Office Action.
U.S. Appl. No. 10/616,832, Jan. 22, 2008, Office Action.
U.S. Appl. No. 10/616,832, Sep. 17, 2008, Office Action.
U.S. Appl. No. 10/616,832, Jul. 21, 2009, Office Action.
U.S. Appl. No. 10/616,832, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, May 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Sep. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/617,090, Mar. 22, 2005, Office Action.
U.S. Appl. No. 10/617,090, Jul. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/617,090, Oct. 5, 2005, Notice of Allowance.
U.S. Appl. No. 10/638,115, Sep. 22, 2006, Office Action.
U.S. Appl. No. 10/638,115, Jan. 31, 2007, Office Action.
U.S. Appl. No. 10/638,115, Sep. 18, 2007, Office Action.
U.S. Appl. No. 10/638,115, Feb. 7, 2008, Office Action.
U.S. Appl. No. 10/638,115, Oct. 29, 2008, Office Action.
U.S. Appl. No. 10/638,115, May 7, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 1, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/638,115, Aug. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/667,144, Sep. 19, 2006, Office Action.
U.S. Appl. No. 10/667,144, May 2, 2007, Office Action.
U.S. Appl. No. 10/667,144, Nov. 19, 2007, Office Action.
U.S. Appl. No. 10/667,144, Dec. 5, 2007, Office Action.
U.S. Appl. No. 10/667,144, May 12, 2008, Office Action.
U.S. Appl. No. 10/667,144, Mar. 24, 2009, Office Action.
U.S. Appl. No. 10/667,144, Nov. 23, 2009, Office Action.
U.S. Appl. No. 10/667,144, Jun. 22, 2010, Office Action.
U.S. Appl. No. 10/667,144, Jun. 6, 2011, Office Action.
U.S. Appl. No. 10/667,144, Oct. 28, 2011, Notice of Allowance.
U.S. Appl. No. 10/669,313, Oct. 31, 2005, Office Action.
U.S. Appl. No. 10/669,313, Jan. 11, 2006, Notice of Allowance.
U.S. Appl. No. 10/669,313, Jun. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/682,459, Sep. 15, 2006, Office Action.
U.S. Appl. No. 10/682,459, Apr. 18, 2007, Office Action.
U.S. Appl. No. 10/682,459, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/682,459, Dec. 4, 2008, Office Action.
U.S. Appl. No. 10/682,459, Jun. 10, 2009, Office Action.
U.S. Appl. No. 10/682,459, Dec. 23, 2009, Office Action.
U.S. Appl. No. 10/682,459, Apr. 28, 2010, Office Action.
U.S. Appl. No. 10/682,459, Oct. 12, 2010, Office Action.
U.S. Appl. No. 10/682,459, Apr. 1, 2011, Notice of Allowance.
U.S. Appl. No. 10/786,444, Oct. 30, 2006, Office Action.
U.S. Appl. No. 10/786,444, Apr. 17, 2007, Office Action.
U.S. Appl. No. 10/786,444, Aug. 31, 2007, Office Action.
U.S. Appl. No. 10/786,444, Apr. 24, 2008, Office Action.
U.S. Appl. No. 10/786,444, Oct. 17, 2008, Office Action.
U.S. Appl. No. 10/786,444, Jun. 18, 2009, Office Action.
U.S. Appl. No. 10/786,444, Jan. 14, 2010, Office Action.
U.S. Appl. No. 10/786,444, Jul. 11, 2013, Notice of Allowance.
U.S. Appl. No. 10/787,073, Nov. 30, 2006, Office Action.
U.S. Appl. No. 10/787,073, Sep. 5, 2007, Office Action.
U.S. Appl. No. 10/787,073, Feb. 22, 2008, Office Action.
U.S. Appl. No. 10/787,073, Nov. 12, 2008, Office Action.
U.S. Appl. No. 10/787,073, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/787,073, Feb. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Aug. 25, 2010, Notice of Allowance.
U.S. Appl. No. 10/908,721, Oct. 19, 2006, Office Action.
U.S. Appl. No. 10/908,721, Aug. 10, 2007, Office Action.
U.S. Appl. No. 10/908,721, Jan. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Nov. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Jun. 23, 2009, Office Action.
U.S. Appl. No. 10/908,721, Feb. 2, 2010, Office Action.
U.S. Appl. No. 10/908,721, Jul. 18, 2013, Notice of Allowance.
U.S. Appl. No. 11/048,503, Mar. 13, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jun. 26, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Apr. 26, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Jul. 30, 2010, Notice of Allowance.
U.S. Appl. No. 11/113,549, Feb. 6, 2007, Office Action.
U.S. Appl. No. 11/113,549, May 30, 2007, Office Action.
U.S. Appl. No. 11/113,549, Nov. 9, 2007, Office Action.
U.S. Appl. No. 11/113,549, Apr. 16, 2008, Office Action.
U.S. Appl. No. 11/113,549, Jul. 21, 2009, Office Action.
U.S. Appl. No. 11/113,549, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/113,549, Jan. 4, 2011, Office Action.
U.S. Appl. No. 11/113,549, Mar. 14, 2014, Notice of Allowance.
U.S. Appl. No. 11/113,549, Jul. 2, 2014, Issue Notification.
U.S. Appl. No. 11/152,562, May 13, 2008, Office Action.
U.S. Appl. No. 11/152,562, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/152,562, Jul. 6, 2009, Office Action.
U.S. Appl. No. 11/152,562, Mar. 31, 2010, Office Action.
U.S. Appl. No. 11/152,562, Sep. 16, 2010, Notice of Allowance.
U.S. Appl. No. 11/198,811, Aug. 26, 2008, Office Action.
U.S. Appl. No. 11/198,811, Apr. 6, 2009, Office Action.
U.S. Appl. No. 11/198,811, Sep. 22, 2009, Office Action.
U.S. Appl. No. 11/198,811, Jun. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/344,793, Jan. 22, 2009, Office Action.
U.S. Appl. No. 11/344,868, Mar. 25, 2009, Office Action.
U.S. Appl. No. 11/344,891, Apr. 29, 2008, Office Action.
U.S. Appl. No. 11/344,891, Dec. 8, 2008, Office Action.
U.S. Appl. No. 11/344,891, Feb. 26, 2009, Office Action.
U.S. Appl. No. 11/344,891, Oct. 7, 2009, Office Action.
U.S. Appl. No. 11/344,891, May 7, 2010, Office Action.
U.S. Appl. No. 11/344,891, Jan. 22, 2013, Notice of Allowance.
U.S. Appl. No. 11/390,586, Jun. 24, 2009, Office Action.
U.S. Appl. No. 11/390,586, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/390,586, May 3, 2012, Notice of Allowance.
U.S. Appl. No. 11/396,141, May 22, 2009, Office Action.
U.S. Appl. No. 11/396,141, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/396,141, May 4, 2010, Office Action.
U.S. Appl. No. 11/396,141, Apr. 30, 2013, Office Action.
U.S. Appl. No. 11/396,141, Aug. 21, 2013, Office Action.
U.S. Appl. No. 11/396,141, Nov. 4, 2013, Notice of Allowance.
U.S. Appl. No. 11/396,731, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/396,731, May 22, 2009, Office Action.
U.S. Appl. No. 11/396,731, Jun. 29, 2010, Office Action.
U.S. Appl. No. 11/396,731, Mar. 22, 2011, Office Action.
U.S. Appl. No. 11/396,731, Sep. 1, 2011, Office Action.
U.S. Appl. No. 11/406,203, May 14, 2007, Office Action.
U.S. Appl. No. 11/406,203, Jan. 29, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, May 23, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Sep. 22, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Mar. 3, 2009, Office Action.
U.S. Appl. No. 11/406,203, Sep. 16, 2009, Office Action.
U.S. Appl. No. 11/406,203, Jun. 18, 2010, Notice of Allowance.
U.S. Appl. No. 11/411,925, Jun. 6, 2007, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2008, Office Action.
U.S. Appl. No. 11/411,925, Jan. 12, 2009, Office Action.
U.S. Appl. No. 11/411,925, Sep. 10, 2009, Office Action.
U.S. Appl. No. 11/411,925, Oct. 1, 2013, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2014, Notice of Allowance.
U.S. Appl. No. 11/411,925, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 11/427,297, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2010, Office Action.
U.S. Appl. No. 11/427,297, Mar. 21, 2011, Office Action.
U.S. Appl. No. 11/427,297, Jun. 26, 2012, Notice of Allowance.
U.S. Appl. No. 11/427,309, May 28, 2008, Office Action.
U.S. Appl. No. 11/427,309, Jan. 2, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 20, 2009, Office Action.
U.S. Appl. No. 11/427,309, Nov. 6, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/427,309, Nov. 15, 2010, Office Action.
U.S. Appl. No. 11/427,309, Jun. 7, 2013, Notice of Allowance.
U.S. Appl. No. 11/455,993, Feb. 17, 2009, Office Action.
U.S. Appl. No. 11/455,993, Dec. 16, 2009, Office Action.
U.S. Appl. No. 11/455,993, Jan. 29, 2014, Office Action.
U.S. Appl. No. 11/532,325, Feb. 23, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jun. 17, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jan. 5, 2010, Office Action.
U.S. Appl. No. 11/532,325, Jul. 17, 2013, Office Action.
U.S. Appl. No. 11/532,325, Dec. 2, 2013, Office Action.
U.S. Appl. No. 11/532,576, Mar. 1, 2010, Office Action.
U.S. Appl. No. 11/532,576, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/532,576, Oct. 13, 2010, Notice of Allowance.
U.S. Appl. No. 11/674,930, Jan. 8, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jun. 4, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jan. 8, 2010, Office Action.
U.S. Appl. No. 11/674,930, Apr. 3, 2014, Notice of Allowance.
U.S. Appl. No. 11/674,930, Jul. 3, 2014, Notice of Allowance.
U.S. Appl. No. 11/675,462, Dec. 10, 2009, Office Action.
U.S. Appl. No. 11/675,462, Aug. 31, 2010, Office Action.
U.S. Appl. No. 11/675,462, Aug. 3, 2011, Office Action.
U.S. Appl. No. 11/675,462, Dec. 22, 2011, Notice of Allowance.
U.S. Appl. No. 11/744,089, Nov. 26, 2008, Office Action.
U.S. Appl. No. 11/744,089, Aug. 14, 2009, Office Action.
U.S. Appl. No. 11/744,089, Aug. 8, 2012, Office Action.
U.S. Appl. No. 11/744,089, Apr. 15, 2013, Office Action.
U.S. Appl. No. 11/744,089, Aug. 8, 2013, Notice of Allowance.
U.S. Appl. No. 11/757,108, Nov. 25, 2009, Office Action.
U.S. Appl. No. 11/767,818, Dec. 24, 2009, Office Action.
U.S. Appl. No. 11/767,818, Mar. 22, 2010, Office Action.
U.S. Appl. No. 11/767,818, Sep. 30, 2010, Office Action.
U.S. Appl. No. 11/767,818, Feb. 16, 2011, Office Action.
U.S. Appl. No. 11/767,818, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 11/852,190, Jun. 24, 2010, Office Action.
U.S. Appl. No. 11/852,190, Nov. 1, 2010, Office Action.
U.S. Appl. No. 11/852,190, Mar. 2, 2011, Office Action.
U.S. Appl. No. 11/852,190, Apr. 24, 2013, Office Action.
U.S. Appl. No. 11/852,190, Nov. 26, 2013, Office Action.
U.S. Appl. No. 11/852,190, Feb. 12, 2014, Notice of Allowance.
U.S. Appl. No. 11/852,190, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 11/958,281, Sep. 2, 2010, Office Action.
U.S. Appl. No. 11/958,281, Oct. 8, 2010, Office Action.
U.S. Appl. No. 11/958,281, Mar. 10, 2011, Office Action.
U.S. Appl. No. 11/958,295, Aug. 27, 2009, Office Action.
U.S. Appl. No. 11/958,295, May 25, 2010, Office Action.
U.S. Appl. No. 11/958,295, Jun. 13, 2014, Notice of Allowance.
U.S. Appl. No. 11/959,334, Aug. 19, 2009, Office Action.
U.S. Appl. No. 11/959,334, Jan. 12, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Apr. 14, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 12/106,928, Jan. 23, 2009, Office Action.
U.S. Appl. No. 12/106,928, Oct. 5, 2009, Office Action.
U.S. Appl. No. 12/106,928, May 10, 2010, Office Action.
U.S. Appl. No. 12/106,928, Oct. 25, 2010, Office Action.
U.S. Appl. No. 12/106,928, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,928, Dec. 2, 2013, Office Action.
U.S. Appl. No. 12/106,928, Mar. 25, 2014, Advisory Action.
U.S. Appl. No. 12/106,937, Mar. 30, 2009, Office Action.
U.S. Appl. No. 12/106,937, Nov. 18, 2009, Office Action.
U.S. Appl. No. 12/106,937, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,937, Jan. 22, 2014, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2010, Office Action.
U.S. Appl. No. 12/113,851, Jun. 24, 2010, Office Action.
U.S. Appl. No. 12/113,851, Dec. 16, 2010, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2011, Office Action.
U.S. Appl. No. 12/113,851, Mar. 29, 2012, Office Action.
U.S. Appl. No. 12/113,851, Mar. 17, 2014, Office Action.
U.S. Appl. No. 12/114,031, Oct. 5, 2010, Office Action.
U.S. Appl. No. 12/114,031, Nov. 22, 2010, Office Action.
U.S. Appl. No. 12/114,031, May 11, 2011, Office Action.
U.S. Appl. No. 12/114,031, Aug. 2, 2011, Office Action.
U.S. Appl. No. 12/114,031, Mar. 6, 2012, Office Action.
U.S. Appl. No. 12/114,031, Mar. 10, 2014, Office Action.
U.S. Appl. No. 12/114,091, Oct. 27, 2010, Office Action.
U.S. Appl. No. 12/114,091, Dec. 17, 2010, Office Action.
U.S. Appl. No. 12/114,091, Jul. 7, 2011, Office Action.
U.S. Appl. No. 12/114,091, Apr. 5, 2012, Office Action.
U.S. Appl. No. 12/114,091, Nov. 8, 2012, Office Action.
U.S. Appl. No. 12/122,603, Mar. 3, 2011, Office Action.
U.S. Appl. No. 12/122,603, Apr. 22, 2011, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2011, Office Action.
U.S. Appl. No. 12/122,603, Nov. 20, 2013, Office Action.
U.S. Appl. No. 12/122,603, Apr. 30, 2014, Office Action.
U.S. Appl. No. 12/135,858, Jul. 13, 2011, Office Action.
U.S. Appl. No. 12/135,858, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/143,020, May 11, 2011, Office Action.
U.S. Appl. No. 12/143,020, Aug. 31, 2011, Office Action.
U.S. Appl. No. 12/143,020, Feb. 23, 2012, Notice of Allowance.
U.S. Appl. No. 12/338,977, Jan. 19, 2012, Office Action.
U.S. Appl. No. 12/338,977, Jul. 11, 2012, Office Action.
U.S. Appl. No. 12/338,977, Nov. 28, 2012, Office Action.
U.S. Appl. No. 12/338,977, Jun. 19, 2013, Office Action.
U.S. Appl. No. 12/393,877, Sep. 29, 2011, Office Action.
U.S. Appl. No. 12/393,877, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/393,877, May 21, 2012, Office Action.
U.S. Appl. No. 12/402,398, Mar. 9, 2010, Office Action.
U.S. Appl. No. 12/402,398, May 20, 2010, Office Action.
U.S. Appl. No. 12/402,398, Jan. 24, 2011, Office Action.
U.S. Appl. No. 12/402,398, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/402,398, Mar. 13, 2013, Notice of Allowance.
U.S. Appl. No. 12/403,256, Dec. 16, 2009, Office Action.
U.S. Appl. No. 12/403,256, Mar. 30, 2010, Office Action.
U.S. Appl. No. 12/403,256, Aug. 19, 2010, Notice of Allowance.
U.S. Appl. No. 12/403,277, Jul. 8, 2010, Office Action.
U.S. Appl. No. 12/403,277, Oct. 12, 2010, Office Action.
U.S. Appl. No. 12/403,277, Mar. 31, 2011, Office Action.
U.S. Appl. No. 12/403,277, Apr. 3, 2012, Office Action.
U.S. Appl. No. 12/403,277, Nov. 5, 2012, Office Action.
U.S. Appl. No. 12/403,277, Jan. 27, 2014, Office Action.
U.S. Appl. No. 12/481,377, Apr. 28, 2011, Office Action.
U.S. Appl. No. 12/481,377, Jun. 21, 2011, Office Action.
U.S. Appl. No. 12/481,377, Jan. 3, 2012, Office Action.
U.S. Appl. No. 12/481,377, Aug. 10, 2012, Notice of Allowance.
U.S. Appl. No. 12/548,274, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/548,274, Mar. 2, 2012, Office Action.
U.S. Appl. No. 12/548,274, Sep. 10, 2012, Office Action.
U.S. Appl. No. 12/608,769, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/608,769, Aug. 22, 2012, Office Action.
U.S. Appl. No. 12/608,769, Nov. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/608,773, Jun. 7, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jul. 20, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jan. 7, 2013, Office Action.
U.S. Appl. No. 12/642,319, Feb. 27, 2012, Office Action.
U.S. Appl. No. 12/642,319, Aug. 28, 2012, Office Action.
U.S. Appl. No. 12/642,319, Dec. 16, 2013, Office Action.
U.S. Appl. No. 12/642,319, May 27, 2014, Notice of Allowance.
U.S. Appl. No. 12/684,400, Feb. 13, 2012, Office Action.
U.S. Appl. No. 12/684,400, May 9, 2012, Office Action.
U.S. Appl. No. 12/684,400, Oct. 16, 2012, Office Action.
U.S. Appl. No. 12/684,470, Dec. 20, 2011, Office Action.
U.S. Appl. No. 12/684,470, Mar. 23, 2012, Office Action.
U.S. Appl. No. 12/684,470, Aug. 30, 2012, Office Action.
U.S. Appl. No. 12/684,470, Jun. 4, 2014, Office Action.
U.S. Appl. No. 12/684,542, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/684,542, Apr. 16, 2012, Office Action.
U.S. Appl. No. 12/684,542, Sep. 13, 2012, Office Action.
U.S. Appl. No. 12/684,542, Jun. 18, 2014, Office Action.
U.S. Appl. No. 12/684,562, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/684,562, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/684,562, Aug. 21, 2012, Office Action.
U.S. Appl. No. 12/684,569, Dec. 20, 2011, Office Action.
U.S. Appl. No. 12/684,569, Jan. 27, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jul. 30, 2012, Office Action.
U.S. Appl. No. 12/684,569, Apr. 23, 2014, Office Action.
U.S. Appl. No. 12/688,065, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/688,065, Apr. 26, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 12, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 18, 2013, Office Action.
U.S. Appl. No. 12/688,065, Apr. 8, 2014, Office Action.
U.S. Appl. No. 12/724,304, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/848,642, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/848,642, Nov. 9, 2012, Office Action.
U.S. Appl. No. 12/848,642, Apr. 26, 2013, Office Action.
U.S. Appl. No. 12/848,642, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/848,642, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 12/850,242, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/850,242, Oct. 17, 2012, Office Action.
U.S. Appl. No. 12/850,242, Apr. 18, 2013, Office Action.
U.S. Appl. No. 12/850,242, Aug. 6, 2013, Notice of Allowance.
U.S. Appl. No. 12/897,358, Aug. 22, 2011, Office Action.
U.S. Appl. No. 12/897,358, Jan. 12, 2012, Notice of Allowance.
U.S. Appl. No. 12/897,358, Mar. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/941,809, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/941,809, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jun. 1, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/941,809, Nov. 8, 2013, Office Action.
U.S. Appl. No. 12/941,809, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/941,809, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 12/945,646, Jan. 20, 2011, Office Action.
U.S. Appl. No. 12/945,646, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/945,646, Oct. 26, 2011, Office Action.
U.S. Appl. No. 12/945,646, Feb. 21, 2012, Notice of Allowance.
U.S. Appl. No. 12/950,628, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/955,859, May 26, 2011, Office Action.
U.S. Appl. No. 12/955,859, Jul. 21, 2011, Office Action.
U.S. Appl. No. 12/955,859, Dec. 15, 2011, Office Action.
U.S. Appl. No. 12/955,859, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/955,859, May 16, 2013, Office Action.
U.S. Appl. No. 12/955,859, Aug. 1, 2013, Notice of Allowance.
U.S. Appl. No. 12/961,331, Dec. 4, 2012, Office Action.
U.S. Appl. No. 12/961,331, Feb. 1, 2013, Office Action.
U.S. Appl. No. 12/961,331, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/961,331, Sep. 20, 2013, Advisory Action.
U.S. Appl. No. 12/961,331, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/966,923, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/973,204, Mar. 7, 2012, Notice of Allowance.
U.S. Appl. No. 12/987,792, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/987,792, Sep. 17, 2012, Office Action.
U.S. Appl. No. 12/987,792, Jan. 21, 2014, Office Action.
U.S. Appl. No. 12/987,792, Jun. 11, 2014, Office Action.
U.S. Appl. No. 13/026,989, Sep. 16, 2011, Office Action.
U.S. Appl. No. 13/026,989, Jun. 8, 2012, Office Action.
U.S. Appl. No. 13/026,989, Aug. 23, 2013, Office Action.
U.S. Appl. No. 13/030,922, Dec. 18, 2012, Office Action.
U.S. Appl. No. 13/030,922, Jan. 31, 2013, Office Action.
U.S. Appl. No. 13/030,922, Jul. 18, 2013, Office Action.
U.S. Appl. No. 13/030,922, Jan. 8, 2014, Notice of Allowance.
U.S. Appl. No. 13/039,087, Jul. 17, 2012, Office Action.
U.S. Appl. No. 13/039,087, Nov. 6, 2012, Notice of Allowance.
U.S. Appl. No. 13/112,618, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,618, Jun. 7, 2013, Office Action.
U.S. Appl. No. 13/112,618, Nov. 20, 2013, Office Action.
U.S. Appl. No. 13/112,631, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,631, Jun. 26, 2013, Office Action.
U.S. Appl. No. 13/112,631, Dec. 2, 2013, Office Action.
U.S. Appl. No. 13/153,594, Jan. 29, 2013, Office Action.
U.S. Appl. No. 13/153,594, May 29, 2013, Office Action.
U.S. Appl. No. 13/153,594, Oct. 16, 2013, Notice of Allowance.
U.S. Appl. No. 13/222,899, Jan. 10, 2014, Office Action.
U.S. Appl. No. 13/308,227, Apr. 10, 2013, Office Action.
U.S. Appl. No. 13/308,227, Sep. 11, 2013, Office Action.
U.S. Appl. No. 13/488,233, Feb. 5, 2013, Notice of Allowance.
U.S. Appl. No. 13/490,143, Jan. 4, 2013, Office Action.
U.S. Appl. No. 13/490,143, Apr. 29, 2013, Notice of Allowance.
U.S. Appl. No. 13/525,839, Apr. 1, 2013, Office Action.
U.S. Appl. No. 13/525,839, Jul. 15, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,547, Jan. 18, 2013, Office Action.
U.S. Appl. No. 13/615,547, Apr. 12, 2013, Notice of Allowance.
U.S. Appl. No. 13/791,829, May 29, 2013, Office Action.
U.S. Appl. No. 13/791,829, Oct. 8, 2013, Notice of Allowance.
U.S. Appl. No. 13/898,202, Jan. 3, 2014, Office Action.
U.S. Appl. No. 29/296,370, Aug. 18, 2008, Office Action.
U.S. Appl. No. 29/296,370, Dec. 2, 2008, Notice of Allowance.
U.S. Appl. No. 29/296,370, Apr. 1, 2009, Notice of Allowance.
U.S. Appl. No. 14/839,658, filed Aug. 31, 2015, Cummins et al.
U.S. Appl. No. 14/855,080, filed Sep. 15, 2015, Voss et al.
U.S. Appl. No. 11/396,731, Feb. 12, 2015, Office Action.
U.S. Appl. No. 11/396,731, Jul. 9, 2015, Notice of Allowance.
U.S. Appl. No. 11/455,993, Aug. 11, 2014, Notice of Allowance.
U.S. Appl. No. 11/532,325, Jan. 16, 2015, Notice of Allowance.
U.S. Appl. No. 12/106,928, Oct. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/106,937, Mar. 5, 2015, Notice of Allowance.
U.S. Appl. No. 12/113,851, Aug. 21, 2014, Office Action.
U.S. Appl. No. 12/113,851, Feb. 20, 2015, Notice of Allowance.
U.S. Appl. No. 12/114,091, Feb. 12, 2015, Office Action.
U.S. Appl. No. 12/114,091, Jul. 23, 2015, Office Action.
U.S. Appl. No. 12/122,603, Apr. 9, 2015, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2015, Notice of Allowance.
U.S. Appl. No. 12/393,877, Aug. 4, 2014, Notice of Allowance.
U.S. Appl. No. 12/403,277, Aug. 15, 2014, Office Action.
U.S. Appl. No. 12/548,274, Aug. 14, 2014, Office Action.
U.S. Appl. No. 12/608,773, Jul. 17, 2014, Office Action.
U.S. Appl. No. 12/608,773, Mar. 12, 2015, Office Action.
U.S. Appl. No. 12/608,773, Sep. 17, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,400, Feb. 23, 2015, Office Action.
U.S. Appl. No. 12/684,400, Jul. 28, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,400, Oct. 14, 2015, Issue Notification.
U.S. Appl. No. 12/684,470, Nov. 14, 2014, Office Action.
U.S. Appl. No. 12/684,470, Aug. 26, 2015, Office Action.
U.S. Appl. No. 12/684,542, Dec. 1, 2014, Office Action.
U.S. Appl. No. 12/684,562, Sep. 10, 2014, Office Action.
U.S. Appl. No. 12/684,562, Feb. 17, 2015, Notice of Allowance.
U.S. Appl. No. 12/987,792, Aug. 25, 2014, Notice of Allowance.
U.S. Appl. No. 13/112,618, Dec. 15, 2014, Office Action.
U.S. Appl. No. 13/112,618, May 18, 2015, Office Action.
U.S. Appl. No. 13/112,631, Nov. 20, 2014, Office Action.
U.S. Appl. No. 13/112,631, Apr. 15, 2015, Office Action.
U.S. Appl. No. 13/222,899, Jul. 31, 2014, Office Action.
U.S. Appl. No. 13/222,899, Apr. 1, 2015, Office Action.
U.S. Appl. No. 13/222,899, Aug. 5, 2015, Office Action.
U.S. Appl. No. 13/308,227, Jul. 14, 2015, Office Action.
U.S. Appl. No. 13/791,846, Jun. 4, 2015, Office Action.
U.S. Appl. No. 13/791,846, Oct. 27, 2015, Notice of Allowance.
U.S. Appl. No. 13/898,202, Aug. 21, 2014, Office Action.
U.S. Appl. No. 13/898,202, Feb. 10, 2015, Notice of Allowance.
U.S. Appl. No. 13/908,796, Jul. 21, 2015, Office Action.
U.S. Appl. No. 14/017,039, Jan. 23, 2015, Office Action.
U.S. Appl. No. 14/017,039, Jun. 10, 2015, Office Action.
U.S. Appl. No. 14/017,039, Oct. 27, 2015, Office Action.
U.S. Appl. No. 14/023,428, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/077,007, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/246,926, Aug. 5, 2015, Office Action.
U.S. Appl. No. 14/246,973, Aug. 3, 2015, Office Action.
U.S. Appl. No. 14/466,576, Jul. 8, 2015, Office Action.
U.S. Appl. No. 14/928,950, filed Oct. 30, 2015, Voss.
Carpenter et al, Midterm results of the multicenter trial of the Powerlink bifurcated system for endovascular aortic aneurysm repair, Journal of Vascular Surgery, vol. 40, No. 5, Nov. 2004, p. 849-859.e5.
Eisenack et al, Percutaneous Endovascular Aortic Aneurysm Repair: A Prospective Evaluation of Safety, Efficiency, and Risk Factors, Journal of Endovascular Ther., 2009, vol. 16, p. 708-713.
Greenhalgh et al, Endovascular versus open repair of abdominal aortic aneurysm, The New England journal of medicine, vol. 362, No. 20, 2010, p. 1863-1871.
Grossman, W., Cardiac Catheterization and Angiography, 3rd Ed., Lea & Febiger, Philadelphia, pp. 1-49, 52-247. 1986.
Howell et al, Percutaneous Repair of Abdominal Aortic Aneurysms Using the aneuRx Stent Graft and the Percutaneous Vascular Surgery Device, Catheterization and cardiovascular interventions, vol. 55, No. 3, 2002, p. 281-287.
Jean-Baptiste et al., Percutaneous closure devices for endovascular repair of infrarenal abdominal aortic aneurysms: a prospective, non-randomized comparative study, European Journal of Vascular and Endovascular Surgery, vol. 35, No. 4, 2008, p. 422-428.
Krajcer and Gregoric, Totally percutaneous aortic aneurysm repair: methods and outcomes using the fully integrated IntuiTrak endovascular system, The Journal of cardiovascular surgery, vol. 51, No. 4, 2010, p. 493-501.
Lederle et al, Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial, Jama, vol. 302, No. 14, 2009, p. 1535-1542.
Lee et al, Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique), Journal of vascular surgery, vol. 45, No. 6, 2007, p. 1095-1101.
Malkawi et al, Percutaneous access for endovascular aneurysm repair: a systematic review, European Journal of Vascular and Endovascular Surgery, vol. 39, No. 6, 2010, p. 676-682.
Morasch et al, Percutaneous repair of abdominal aortic aneurys, Journal of vascular surgery, vol. 40, No. 1, 2004, p. 12-16.
Rachel et al, Percutaneous endovascular abdominal aortic aneurysm repair, Annals of vascular surgery, vol. 16, No. 1, 2002, p. 43-49.
Starnes et al, Totally percutaneous aortic aneurysm repair: experience and prudence, Journal of vascular surgery, vol. 43, No. 2, 2006, p. 270-276.
Teh et al, Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience, European Journal of Vascular and Endovascular Surgery, vol. 22, No. 5, 2001, p. 418-423.
Torsello et al, Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study, Journal of vascular surgery, vol. 38, No. 1, 2003, p. 78-82.
Traul et al, Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study, Journal of vascular surgery, vol. 32, No. 4, 2000, p. 770-776.
Watelet et al, Percutaneous repair of aortic aneurysms: a prospective study of suture-mediated closure devices, European journal of vascular and endovascular surgery, vol. 32, No. 3, 2006, p. 261-265.
U.S. Appl. No. 12/684,470, Jan. 21, 2016, Office Action.
U.S. Appl. No. 13/222,899, Jan. 7, 2016, Notice of Allowance.
U.S. Appl. No. 13/725,589, Sep. 17, 2015, Office Action.
U.S. Appl. No. 13/837,801, Dec. 16, 2015, Office Action.
U.S. Appl. No. 13/908,796, Nov. 6, 2015, Notice of Allowance.
U.S. Appl. No. 14/246,926, Nov. 23, 2015, Office Action.
U.S. Appl. No. 14/246,973, Nov. 24, 2015, Office Action.
U.S. Appl. No. 14/312,339, Jan. 22, 2016, Office Action.
U.S. Appl. No. 14/466,576, Dec. 15, 2015, Notice of Allowance.
U.S. Appl. No. 15/056,281, filed Feb. 29, 2015, Palermo et al.
U.S. Appl. No. 15/056,281, filed Mar. 15, 2015, Kokish.
U.S. Appl. No. 15/005,780, filed Jan. 26, 2015, Mehl.
U.S. Appl. No. 12/114,091, Apr. 6, 2016, Notice of Allowance.
U.S. Appl. No. 13/112,618, Jan. 29, 2016, Office Action.
U.S. Appl. No. 13/222,899, Apr. 6, 2016, Issue Notification.
U.S. Appl. No. 13/308,227, Feb. 1, 2016, Notice of Allowance.
U.S. Appl. No. 13/725,589, Mar. 18, 2016, Notice of Allowance.
U.S. Appl. No. 14/017,039, Apr. 4, 2016, Notice of Allowance.
U.S. Appl. No. 14/023,428, Feb. 9, 2016, Office Action
U.S. Appl. No. 14/077,007, Jan. 29, 2016, Office Action.
U.S. Appl. No. 14/466,576, Mar. 30, 2016, Issue Notification.
U.S. Appl. No. 14/539,830, Jan. 29, 2016, Office Action.
Related Publications (1)
Number Date Country
20140364900 A1 Dec 2014 US
Provisional Applications (1)
Number Date Country
61145468 Jan 2009 US
Divisions (1)
Number Date Country
Parent 12688065 Jan 2010 US
Child 14323753 US